Oral contraceptives which owe their effectiveness to synthetic preparations.
The 3-methyl ether of ETHINYL ESTRADIOL. It must be demethylated to be biologically active. It is used as the estrogen component of many combination ORAL CONTRACEPTIVES.
Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both.
A synthetic progestational agent with actions similar to those of PROGESTERONE. This racemic or (+-)-form has about half the potency of the levo form (LEVONORGESTREL). Norgestrel is used as a contraceptive, ovulation inhibitor, and for the control of menstrual disorders and endometriosis.
Chemical substances that prevent or reduce the probability of CONCEPTION.
Fixed drug combinations administered orally for contraceptive purposes.
A synthetic progestational hormone with actions similar to those of PROGESTERONE but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for contraception.
A synthetic progestational hormone used alone or in combination with estrogens as an oral contraceptive.
Chemical substances which inhibit the process of spermatozoa formation at either the first stage, in which spermatogonia develop into spermatocytes and then into spermatids, or the second stage, in which spermatids transform into spermatozoa.
A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES.
A synthetic progestational hormone used often in mixtures with estrogens as an oral contraceptive.
Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading.
ETHINYL ESTRADIOL and NORGESTREL given in fixed proportions. It has proved to be an effective contraceptive (CONTRACEPTIVES, ORAL, COMBINED).
Xanthurenic acid and its salts, formed as byproducts during the metabolism of tryptophan, are collectively referred to as xanthurenates, which can accumulate in conditions like hyperphenylalaninemia and may contribute to oxidative stress and cellular damage.
Oral contraceptives which owe their effectiveness to hormonal preparations.
Chemical substances that are destructive to spermatozoa used as topically administered vaginal contraceptives.
Chemical substances or agents with contraceptive activity in males. Use for male contraceptive agents in general or for which there is no specific heading.
Devices that diminish the likelihood of or prevent conception. (From Dorland, 28th ed)
Prevention of CONCEPTION by blocking fertility temporarily, or permanently (STERILIZATION, REPRODUCTIVE). Common means of reversible contraception include NATURAL FAMILY PLANNING METHODS; CONTRACEPTIVE AGENTS; or CONTRACEPTIVE DEVICES.
The 4-methanol form of VITAMIN B 6 which is converted to PYRIDOXAL PHOSPHATE which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. Although pyridoxine and Vitamin B 6 are still frequently used as synonyms, especially by medical researchers, this practice is erroneous and sometimes misleading (EE Snell; Ann NY Acad Sci, vol 585 pg 1, 1990).
The periodic shedding of the ENDOMETRIUM and associated menstrual bleeding in the MENSTRUAL CYCLE of humans and primates. Menstruation is due to the decline in circulating PROGESTERONE, and occurs at the late LUTEAL PHASE when LUTEOLYSIS of the CORPUS LUTEUM takes place.
Contraceptive devices used by females.
Behavior patterns of those practicing CONTRACEPTION.
Nutritional factor found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables. The richest natural source is yeast. It occurs in the free form only in the retina of the eye, in whey, and in urine; its principal forms in tissues and cells are as FLAVIN MONONUCLEOTIDE and FLAVIN-ADENINE DINUCLEOTIDE.
Disorders caused by nutritional imbalance, either overnutrition or undernutrition.
Contraceptive devices placed high in the uterine fundus.
Health care programs or services designed to assist individuals in the planning of family size. Various methods of CONTRACEPTION can be used to control the number and timing of childbirths.
A heavy metal trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63.55.
A synthetic progestational hormone used often as the progestogenic component of combined oral contraceptive agents.
A synthetic progestational hormone with actions similar to those of PROGESTERONE and about twice as potent as its racemic or (+-)-isomer (NORGESTREL). It is used for contraception, control of menstrual disorders, and treatment of endometriosis.
Contraceptive substances to be used after COITUS. These agents include high doses of estrogenic drugs; progesterone-receptor blockers; ANTIMETABOLITES; ALKALOIDS, and PROSTAGLANDINS.
A metallic element of atomic number 30 and atomic weight 65.38. It is a necessary trace element in the diet, forming an essential part of many enzymes, and playing an important role in protein synthesis and in cell division. Zinc deficiency is associated with ANEMIA, short stature, HYPOGONADISM, impaired WOUND HEALING, and geophagia. It is known by the symbol Zn.
Vaccines or candidate vaccines used to prevent conception.
Unintended accidental pregnancy, including pregnancy resulting from failed contraceptive measures.
Procedures to block or remove all or part of the genital tract for the purpose of rendering individuals sterile, incapable of reproduction. Surgical sterilization procedures are the most commonly used. There are also sterilization procedures involving chemical or physical means.
Pregnancy, usually accidental, that is not desired by the parent or parents.
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
A synthetic progestin that is derived from 17-hydroxyprogesterone. It is a long-acting contraceptive that is effective both orally or by intramuscular injection and has also been used to treat breast and endometrial neoplasms.
Means of postcoital intervention to avoid pregnancy, such as the administration of POSTCOITAL CONTRACEPTIVES to prevent FERTILIZATION of an egg or implantation of a fertilized egg (OVUM IMPLANTATION).
Intrauterine contraceptive devices that depend on the release of metallic copper.
A synthetic progestational hormone with actions and uses similar to those of PROGESTERONE. It has been used in the treatment of functional uterine bleeding and endometriosis. As a contraceptive, it has usually been administered in combination with MESTRANOL.
Intentional removal of a fetus from the uterus by any of a number of techniques. (POPLINE, 1978)
Contraceptive methods based on immunological processes and techniques, such as the use of CONTRACEPTIVE VACCINES.
Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY.
Pregnenes with one double bond or more than three double bonds which have undergone ring contractions or are lacking carbon-18 or carbon-19..
Drugs administered orally and sequentially for contraceptive purposes.
Postcoital contraceptives which owe their effectiveness to hormonal preparations.
Procedures that render the female sterile by interrupting the flow in the FALLOPIAN TUBE. These procedures generally are surgical, and may also use chemicals or physical means.
The capacity to conceive or to induce conception. It may refer to either the male or female.
The period from onset of one menstrual bleeding (MENSTRUATION) to the next in an ovulating woman or female primate. The menstrual cycle is regulated by endocrine interactions of the HYPOTHALAMUS; the PITUITARY GLAND; the ovaries; and the genital tract. The menstrual cycle is divided by OVULATION into two phases. Based on the endocrine status of the OVARY, there is a FOLLICULAR PHASE and a LUTEAL PHASE. Based on the response in the ENDOMETRIUM, the menstrual cycle is divided into a proliferative and a secretory phase.
Knowledge, attitudes, and associated behaviors which pertain to health-related topics such as PATHOLOGIC PROCESSES or diseases, their prevention, and treatment. This term refers to non-health workers and health workers (HEALTH PERSONNEL).
The number of offspring a female has borne. It is contrasted with GRAVIDITY, which refers to the number of pregnancies, regardless of outcome.
The female reproductive organs. The external organs include the VULVA; BARTHOLIN'S GLANDS; and CLITORIS. The internal organs include the VAGINA; UTERUS; OVARY; and FALLOPIAN TUBES.
Unsaturated derivatives of the steroid androstane containing at least one double bond at any site in any of the rings.
Steroidal compounds related to PROGESTERONE, the major mammalian progestational hormone. Progesterone congeners include important progesterone precursors in the biosynthetic pathways, metabolites, derivatives, and synthetic steroids with progestational activities.
Intrauterine devices that release contraceptive agents.
Contraceptive devices used by males.
Variations of menstruation which may be indicative of disease.
Small containers or pellets of a solid drug implanted in the body to achieve sustained release of the drug.
Pregnancy in human adolescent females under the age of 19.
Sexual activities of humans.
17-Hydroxy-6-methylpregna-3,6-diene-3,20-dione. A progestational hormone used most commonly as the acetate ester. As the acetate, it is more potent than progesterone both as a progestagen and as an ovulation inhibitor. It has also been used in the palliative treatment of breast cancer.
Education which increases the knowledge of the functional, structural, and behavioral aspects of human reproduction.
Postcoital contraceptives which owe their effectiveness to synthetic preparations.
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
A sheath that is worn over the penis during sexual behavior in order to prevent pregnancy or spread of sexually transmitted disease.
Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds.
Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances.
Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time.
Those characteristics that distinguish one SEX from the other. The primary sex characteristics are the OVARIES and TESTES and their related hormones. Secondary sex characteristics are those which are masculine or feminine but not directly related to reproduction.
Blocking the process leading to OVULATION. Various factors are known to inhibit ovulation, such as neuroendocrine, psychological, and pharmacological agents.
(6 alpha)-17-Hydroxy-6-methylpregn-4-ene-3,20-dione. A synthetic progestational hormone used in veterinary practice as an estrus regulator.
Pregnadienes which have undergone ring contractions or are lacking carbon-18 or carbon-19.
A medicated adhesive patch placed on the skin to deliver a specific dose of medication into the bloodstream.
Steroidal compounds related to ESTRADIOL, the major mammalian female sex hormone. Estradiol congeners include important estradiol precursors in the biosynthetic pathways, metabolites, derivatives, and synthetic steroids with estrogenic activities.
17 alpha-Hydroxypregn-4-en-20-yn-3-one. A synthetic steroid hormone with progestational effects.
Bleeding from blood vessels in the UTERUS, sometimes manifested as vaginal bleeding.
Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument.
Elements of limited time intervals, contributing to particular results or situations.
Abnormal uterine bleeding that is not related to MENSTRUATION, usually in females without regular MENSTRUAL CYCLE. The irregular and unpredictable bleeding usually comes from a dysfunctional ENDOMETRIUM.
A soft, loose-fitting polyurethane sheath, closed at one end, with flexible rings at both ends. The device is inserted into the vagina by compressing the inner ring and pushing it in. Properly positioned, the ring at the closed end covers the cervix, and the sheath lines the walls of the vagina. The outer ring remains outside the vagina, covering the labia. (Med Lett Drugs Ther 1993 Dec 24;35(12):123)
The sexual union of a male and a female, a term used for human only.
Sexual activities of animals.
The total process by which organisms produce offspring. (Stedman, 25th ed)
Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.
Statistical models which describe the relationship between a qualitative dependent variable (that is, one which can take only certain discrete values, such as the presence or absence of a disease) and an independent variable. A common application is in epidemiology for estimating an individual's risk (probability of a disease) as a function of a given risk factor.
Diseases due to or propagated by sexual contact.
Nonionic surfactant mixtures varying in the number of repeating ethoxy (oxy-1,2-ethanediyl) groups. They are used as detergents, emulsifiers, wetting agents, defoaming agents, etc. Nonoxynol-9, the compound with 9 repeating ethoxy groups, is a spermatocide, formulated primarily as a component of vaginal foams and creams.
Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time.
The concept covering the physical and mental conditions of women.
Individuals requesting induced abortions.
The social institution involving legal and/or religious sanction whereby individuals are joined together.
Health care services related to human REPRODUCTION and diseases of the reproductive system. Services are provided to both sexes and usually by physicians in the medical or the surgical specialties such as REPRODUCTIVE MEDICINE; ANDROLOGY; GYNECOLOGY; OBSTETRICS; and PERINATOLOGY.
Termination of pregnancy under conditions allowed under local laws. (POPLINE Thesaurus, 1991)
Absence of menstruation.
An important aggregate factor in epidemiological studies of women's health. The concept usually includes the number and timing of pregnancies and their outcomes, the incidence of breast feeding, and may include age of menarche and menopause, regularity of menstruation, fertility, gynecological or obstetric problems, or contraceptive usage.

Provider attitudes toward dispensing emergency contraception in Michigan's Title X programs.(1/444)

 (+info)

The effects of levonorgestrel implants on vascular endothelial growth factor expression in the endometrium. (2/444)

Vascular endothelial growth factor (VEGF) expression and the microvascular density of the endometrium were studied in Norplant users and normal controls, using immunohistochemistry on formalin-fixed paraffin-embedded endometrial sections. The VEGF staining index was quantified using computerized image analysis. The VEGF staining index between stages of the menstrual cycle and between normal and Norplant endometria were compared. Norplant VEGF staining index was analysed for correlation with microvascular density, duration of Norplant use, the number of bleeding/spotting days in the reference period up to 90 days prior to biopsy, and the length of time since the last bleeding/spotting episode. The results showed that immunoreactive VEGF was detected predominantly in endometrial glands but weakly expressed in the stroma throughout the menstrual cycle, and also in Norplant users. Large variation in the VEGF staining index between individuals was observed and no significant difference in the VEGF staining index was detected between stages of the menstrual cycle for the glands and stroma. The glandular and stromal VEGF staining indices were significantly higher in Norplant than in normal endometrium (P<1x10(-4)). No correlation was found between the Norplant VEGF staining index and endometrial microvascular density, duration of Norplant use, the number of bleeding/spotting days in the reference period, and the length of time since the last bleeding/spotting episode. The VEGF staining index was higher in glands than stroma for both normal and Norplant endometrium. The results suggest a differential control of endometrial glandular versus stromal VEGF expression, and possible positive effects of levonorgestrel on VEGF expression.  (+info)

Levonorgestrel versus the "Yuzpe" regimen.(3/444)

New choices in emergency contraception.  (+info)

Three countries' experience with Norplant introduction. (4/444)

Despite international efforts to plan for Norplant introduction, the method has drawn the attention of critics of family planning programmes, and has raised several issues for debate since it was introduced into family planning programmes. The experiences of three countries with the introduction of Norplant highlight some of the unique features of the method that have affected its introduction. Indonesia, Bangladesh and the United States represent diverse cultural settings and systems of family planning provision. Experience in each country has highlighted the need to focus on quality of care for clients, most notably the need for good counselling and attention to removal as well as insertion. The cost of Norplant also has influenced its introduction in each country. Another issue includes the need to work with women's health advocacy groups, which is illustrated particularly in Bangladesh. Finally, the role of litigation in the United States, and its potential role in influencing Norplant introduction in other countries, is discussed. These three countries' experience illustrate the importance of understanding the programmatic context of contraceptive introduction.  (+info)

Dose linearity study of selegiline pharmacokinetics after oral administration: evidence for strong drug interaction with female sex steroids. (5/444)

AIMS: The purpose of this study was to characterize the dose relationship of selegline and desmethylselegiline pharmacokinetics within the selegiline dose range from 5 to 40 mg. METHODS: Eight female subjects, of whom four were using oral contraceptives, ingested a single dose of 5 mg, 10 mg, 20 mg or 40 mg of selegiline HCl in an open four-period randomized study. Concentrations of selegiline and desmethlylselegiline in serum were measured by gas chromatography for 5 h. As it became evident that the use of oral steroids had a drastic effect on selegiline concentrations, the pharmacokinetic analyses were performed separately for oral contraceptive users and those not receiving any concomitant medication. RESULTS: The total AUC and Cmax of selegiline were 10-to 20-fold higher in those subjects taking oral steroids compared with subjects with no concomitant medication; this finding was consistent and statistically significant at all the four dose levels. The dose linearity of selegiline pharmacokinetics failed to be demonstrated in both groups. The AUC and Cmax of desmethylselegiline were only moderately higher (about 1.5-fold; P=NS at each dose level) in the subjects taking oral steroids than in those not receiving concomitant medication. The AUC values of desmethylselegiline increased in a dose linear manner in subjects with no concomitant medication, but not in the oral steroid group. The metabolic ratio (AUC(desmethylselegiline)/AUC(selegiline)) was several-fold lower in the group receiving oral steroids compared with the no-concomitant-medication group (P<0.005 at all the four dose levels). CONCLUSIONS: Concomitant use of oral contraceptives caused a drastic (20-fold) increase in the oral bioavailability of selegiline. The highly significant difference in the metabolic ratio between the groups provides evidence that the mechanism of the interaction between selegiline and female sex steroids involves reduced T-demethylation of selegiline. The present results suggest that concomitant use of selegiline with exogenous female sex steroids should be avoided or the dosage of selegiline should be reduced in order to minimize the risks of selegiline related adverse drug reactions.  (+info)

The effect of a levonorgestrel-releasing intrauterine device on human endometrial oestrogen and progesterone receptors after one year of use. (6/444)

Thirty-four women bearing a levonorgestrel-releasing intrauterine device, 20 micrograms/day (LNG-IUD-20), for 12-15 months were recruited. Endometrial biopsies were collected during the late proliferative phase of the cycle (on cycle days 10-12) before (control) and after the use of the IUD for 12 months, and assayed for oestrogen receptors (ER) and progesterone receptors (PR). An immunohistochemical technique with the peroxidase-antiperoxidase detection system (PAP method) was employed. D75 and JZB39 were the primary antibodies for ER and PR respectively. The immunostaining semiquantitative analysis was performed with a computerized microscope image processor, and expressed as 'grey value'. Both endometrial ER and PR populations were significantly lower after insertion of the IUD (P < 0.01) than in control biopsies. The intensity of nuclear staining and the percentage of positively stained cells for ER and PR in women with LNG-IUD were each about 50% of those in control biopsies. The results suggested that LNG released locally from the IUD has a depressive action on the ER and PR, which may contribute to the contraceptive effectiveness of this type of IUD and also to the possible causes of LNG-IUD-induced irregular bleeding and amenorrhoea.  (+info)

A multicentre efficacy and safety study of the single contraceptive implant Implanon. Implanon Study Group. (7/444)

An open, multicentre study was performed to assess efficacy, safety and acceptability of the single-rod contraceptive implant Implanon. The study involved 635 young healthy women, who were sexually active and of childbearing potential. The women were followed up every 3 months over the entire study period. Originally the study was designed for 2 years, but was extended to 3 years in a group of 147 women from two centres. Altogether, 21 centres in nine different countries participated. The average age of the women was 29 years (range 18-42 years), of whom 83.5% had been pregnant in the past. No pregnancy occurred during treatment with Implanon, resulting in a Pearl Index of 0 (95% confidence interval: 0.0-0.2). In the first 2 years, 31% had discontinued the treatment. Of the 147 women in the study extension, nine discontinued (6%) treatment. Bleeding irregularities was the main reason for discontinuation during the first 2 years of use (17.2%) and adverse experiences in the third year (3.4%). Implant insertion and removal were fast and uncomplicated in the vast majority (97%) of cases. Return of fertility was prompt. In conclusion, Implanon has excellent contraceptive action during its lifetime of 3 years. The safety profile is acceptable and not essentially different from progestogens in general.  (+info)

Changes in vascular basement membrane in the endometrium of Norplant users. (8/444)

Progestogen-only contraception is almost invariably associated with changes in menstrual bleeding patterns. Changes in the endometrial vasculature, and in particular an increase in vascular fragility, may contribute to this bleeding. In this study, endometrial vascular density and endothelial cell basement membrane components were examined using immunohistochemistry before and after insertion of Norplant. Endometrial vascular density was increased from a mean (+/- SEM) of 189.6 +/- 7.0 vessels/mm2 during the control cycle to 253.9 +/- 80.7 vessels/mm2 at 2-13 weeks of Norplant exposure, and to 212.7 +/- 12.9 vessels/mm2 at 14-42 weeks. During the control cycle, a mean of 161.4 +/- 4.5 vessels/mm2 stained for collagen IV (85% of all vessels), while at 2-13 weeks, 144.5 +/- 13.0 vessels/mm2 stained for collagen IV (57% of all vessels) (t ratio = 2.08, P = 0.0057). By 14-42 weeks, 71% of vessels (151.0 +/- 9.8) vessels/mm2 were surrounded by collagen IV. This was not significantly different from control values (t ratio = 2.03). Endometrial vascular laminin was also reduced following Norplant insertion, from a mean of 176.0 +/- 4.2 vessels/mm2 in the control cycle (93% of vessels), to 156.3 +/- 6.7 vessels/mm2 at 2-13 weeks of exposure (57% of vessels) (t ratio = 2.08, P = 0.01). By 14-42 weeks of exposure to Norplant, 162.5 +/- 9 vessels/mm2 (76%) stained for laminin. This was not significantly different from control values (t ratio = 2.04). Endometrial vascular heparan sulphate proteoglycan (HSPG) was reduced from 58.6 +/- 3.0 vessels/mm2 during the control cycle (31% of vessels) to 43.6 +/- 5.6 vessels/mm2 (only 17% of vessels) at 2-13 weeks (t ratio = 2.08, P = 0.025). At 14-42 weeks, only 19% of vessels stained for HSPG (41.3 +/- 5.8 vessels/mm2; t ratio = 2.04, P = 0.009).  (+info)

Oral contraceptives, also known as "birth control pills," are synthetic hormonal medications that are taken by mouth to prevent pregnancy. They typically contain a combination of synthetic versions of the female hormones estrogen and progesterone, which work together to inhibit ovulation (the release of an egg from the ovaries), thicken cervical mucus (making it harder for sperm to reach the egg), and thin the lining of the uterus (making it less likely that a fertilized egg will implant).

There are several different types of oral contraceptives, including combination pills, progestin-only pills, and extended-cycle pills. Combination pills contain both estrogen and progestin, while progestin-only pills contain only progestin. Extended-cycle pills are a type of combination pill that are taken for 12 weeks followed by one week of placebo pills, which can help reduce the frequency of menstrual periods.

It's important to note that oral contraceptives do not protect against sexually transmitted infections (STIs), so it's still important to use barrier methods like condoms if you are at risk for STIs. Additionally, oral contraceptives can have side effects and may not be suitable for everyone, so it's important to talk to your healthcare provider about the potential risks and benefits before starting to take them.

Mestranol is a synthetic form of estrogen, which is a female sex hormone used in oral contraceptives and hormone replacement therapy. It works by preventing the release of an egg from the ovary (ovulation) and altering the cervical mucus and the lining of the uterus to make it more difficult for sperm to reach the egg or for an already established pregnancy to be implanted.

Mestranol is typically combined with a progestin in birth control pills, such as those known as the "combined oral contraceptives." It's important to note that mestranol has largely been replaced by ethinyl estradiol, which is a more commonly used form of synthetic estrogen in hormonal medications.

As with any medication, there are potential risks and side effects associated with the use of mestranol, including an increased risk of blood clots, stroke, and certain types of cancer. It's essential to consult with a healthcare provider before starting or changing any hormonal medication.

Oral contraceptives, also known as "birth control pills," are medications taken by mouth to prevent pregnancy. They contain synthetic hormones that mimic the effects of natural hormones estrogen and progesterone in a woman's body, thereby preventing ovulation, fertilization, or implantation of a fertilized egg in the uterus.

There are two main types of oral contraceptives: combined pills, which contain both estrogen and progestin, and mini-pills, which contain only progestin. Combined pills work by preventing ovulation, thickening cervical mucus to make it harder for sperm to reach the egg, and thinning the lining of the uterus to make it less likely for a fertilized egg to implant. Mini-pills work mainly by thickening cervical mucus and changing the lining of the uterus.

Oral contraceptives are highly effective when used correctly, but they do not protect against sexually transmitted infections (STIs). It is important to use them consistently and as directed by a healthcare provider. Side effects may include nausea, breast tenderness, headaches, mood changes, and irregular menstrual bleeding. In rare cases, oral contraceptives may increase the risk of serious health problems such as blood clots, stroke, or liver tumors. However, for most women, the benefits of using oral contraceptives outweigh the risks.

**Norgestrel** is a synthetic form of the naturally occurring hormone **progesterone**. It is a type of **progestin**, which is often used in various forms of hormonal birth control to prevent pregnancy. Norgestrel works by thickening cervical mucus, making it more difficult for sperm to reach and fertilize an egg. Additionally, norgestrel can also prevent ovulation (the release of an egg from the ovaries) and thin the lining of the uterus, which makes it less likely for a fertilized egg to implant.

Norgestrel is available in various forms, such as oral contraceptive pills, emergency contraceptives, and hormonal intrauterine devices (IUDs). It's essential to consult with a healthcare provider before starting any hormonal birth control method to discuss potential benefits, risks, and side effects.

Here are some medical definitions related to norgestrel:

1. **Progestin**: A synthetic form of the naturally occurring hormone progesterone, used in various forms of hormonal birth control and menopausal hormone therapy. Progestins can have varying levels of androgenic, estrogenic, and anti-estrogenic activity. Norgestrel is a type of progestin.
2. **Progesterone**: A naturally occurring steroid hormone produced by the ovaries during the second half of the menstrual cycle. Progesterone plays a crucial role in preparing the uterus for pregnancy and maintaining a healthy pregnancy. Norgestrel is a synthetic form of progesterone.
3. **Hormonal birth control**: A method of preventing pregnancy that uses hormones to regulate ovulation, thicken cervical mucus, or thin the lining of the uterus. Hormonal birth control methods include oral contraceptive pills, patches, rings, injections, implants, and intrauterine devices (IUDs).
4. **Emergency contraception**: A form of hormonal birth control used to prevent pregnancy after unprotected sex or contraceptive failure. Emergency contraception is typically more effective when taken as soon as possible after unprotected intercourse, but it can still be effective up to 120 hours afterward. Norgestrel is one of the active ingredients in some emergency contraceptive pills.
5. **Menopausal hormone therapy (MHT)**: A form of hormone replacement therapy used to alleviate symptoms associated with menopause, such as hot flashes and vaginal dryness. MHT typically involves using estrogen and progestin or a selective estrogen receptor modulator (SERM). Norgestrel is a type of progestin that can be used in MHT.
6. **Androgenic**: Describing the effects of hormones, such as testosterone and some progestins, that are associated with male characteristics, such as facial hair growth, deepening of the voice, and increased muscle mass. Norgestrel has weak androgenic activity.
7. **Estrogenic**: Describing the effects of hormones, such as estradiol and some selective estrogen receptor modulators (SERMs), that are associated with female characteristics, such as breast development and menstrual cycles. Norgestrel has weak estrogenic activity.
8. **Antiestrogenic**: Describing the effects of hormones or drugs that block or oppose the actions of estrogens. Norgestrel has antiestrogenic activity.
9. **Selective estrogen receptor modulator (SERM)**: A type of drug that acts as an estrogen agonist in some tissues and an estrogen antagonist in others. SERMs can be used to treat or prevent breast cancer, osteoporosis, and other conditions associated with hormonal imbalances. Norgestrel is not a SERM but has antiestrogenic activity.
10. **Progestogen**: A synthetic or natural hormone that has progesterone-like effects on the body. Progestogens can be used to treat various medical conditions, such as endometriosis, uterine fibroids, and irregular menstrual cycles. Norgestrel is a type of progestogen.
11. **Progesterone**: A natural hormone produced by the ovaries during the second half of the menstrual cycle. Progesterone prepares the uterus for pregnancy and regulates the menstrual cycle. Norgestrel is a synthetic form of progesterone.
12. **Progestin**: A synthetic hormone that has progesterone-like effects on the body. Progestins can be used to treat various medical conditions, such as endometriosis, uterine fibroids, and irregular menstrual cycles. Norgestrel is a type of progestin.
13. **Progestational agent**: A drug or hormone that has progesterone-like effects on the body. Progestational agents can be used to treat various medical conditions, such as endometriosis, uterine fibroids, and irregular menstrual cycles. Norgestrel is a type of progestational agent.
14. **Progestogenic**: Describing the effects of hormones or drugs that mimic or enhance the actions of progesterone. Norgestrel has progestogenic activity.
15. **Progesterone receptor modulator (PRM)**: A type of drug that binds to and activates or inhibits the progesterone receptors in the body. PRMs can be used to treat various medical conditions, such as endometriosis, uterine fibroids, and breast cancer. Norgestrel is a type of PRM.
16. **Progestogenic activity**: The ability of a drug or hormone to mimic or enhance the actions of progesterone in the body. Norgestrel has progestogenic activity.
17. **Progesterone antagonist**: A drug that blocks the action of progesterone in the body. Progesterone antagonists can be used to treat various medical conditions, such as endometriosis, uterine fibroids, and breast cancer. Norgestrel is not a progesterone antagonist.
18. **Progestogenic antagonist**: A drug that blocks the action of progestogens in the body. Progestogenic antagonists can be used to treat various medical conditions, such as endometriosis, uterine fibroids, and breast cancer. Norgestrel is not a progesterone antagonist.
19. **Progesterone agonist**: A drug that enhances the action of progesterone in the body. Progesterone agonists can be used to treat various medical conditions, such as endometriosis, uterine fibroids, and breast cancer. Norgestrel is a progesterone agonist.
20. **Progestogenic agonist**: A drug that enhances the action of progestogens in the body. Progesterogenic agonists can be used to treat various medical conditions, such as endometriosis, uterine fibroids, and breast cancer. Norgestrel is a progesterone agonist.
21. **Progesterone receptor modulator**: A drug that binds to the progesterone receptor and can either activate or inhibit its activity. Progesterone receptor modulators can be used to treat various medical conditions, such as endometriosis, uterine fibroids, and breast cancer. Norgestrel is a progesterone receptor modulator.
22. **Progestogenic receptor modulator**: A drug that binds to the progesterone receptor and can either activate or inhibit its activity. Progesterogenic receptor modulators can be used to treat various medical conditions, such as endometriosis, uterine fibroids, and breast cancer. Norgestrel is a progesterone receptor modulator.
23. **Progestin**: A synthetic form of progesterone that is used in hormonal contraceptives and menopausal hormone therapy. Progestins can be either progesterone agonists or antagonists, depending on their chemical structure and activity at the progesterone receptor. Norgestrel is a progestin.
24. **Progesterone antagonist**: A drug that binds to the progesterone receptor and inhibits its activity. Progesterone antagonists can be used to treat various medical conditions, such as endometriosis, uterine fibroids, and breast cancer. Norgestrel is not a progesterone antagonist.
25. **Progestogenic antagonist**: A drug that binds to the progesterone receptor and inhibits its activity. Progesterogenic antagonists can be used to treat various medical conditions, such as endometriosis, uterine fibro

Contraceptive agents are substances or medications that are used to prevent pregnancy by interfering with the normal process of conception and fertilization or the development and implantation of the fertilized egg. They can be divided into two main categories: hormonal and non-hormonal methods.

Hormonal contraceptive agents include combined oral contraceptives (COCs), progestin-only pills, patches, rings, injections, and implants. These methods work by releasing synthetic hormones that mimic the natural hormones estrogen and progesterone in a woman's body. By doing so, they prevent ovulation, thicken cervical mucus to make it harder for sperm to reach the egg, and thin the lining of the uterus to make it less likely for a fertilized egg to implant.

Non-hormonal contraceptive agents include barrier methods such as condoms, diaphragms, cervical caps, and sponges, which prevent sperm from reaching the egg by creating a physical barrier. Other non-hormonal methods include intrauterine devices (IUDs), which are inserted into the uterus to prevent pregnancy, and fertility awareness-based methods, which involve tracking ovulation and avoiding intercourse during fertile periods.

Emergency contraceptive agents, such as Plan B or ella, can also be used to prevent pregnancy after unprotected sex or contraceptive failure. These methods work by preventing or delaying ovulation, preventing fertilization, or preventing implantation of a fertilized egg.

It's important to note that while contraceptive agents are effective at preventing pregnancy, they do not protect against sexually transmitted infections (STIs). Using condoms in addition to other forms of contraception can help reduce the risk of STIs.

Oral combined contraceptives, also known as "the pill," are a type of hormonal birth control that contain a combination of synthetic estrogen and progestin. These hormones work together to prevent ovulation (the release of an egg from the ovaries), thicken cervical mucus to make it harder for sperm to reach the egg, and thin the lining of the uterus to make it less likely for a fertilized egg to implant.

Combined oral contraceptives come in various brands and forms, such as monophasic, biphasic, and triphasic pills. Monophasic pills contain the same amount of hormones in each active pill, while biphasic and triphasic pills have varying amounts of hormones in different phases of the cycle.

It is important to note that oral combined contraceptives do not protect against sexually transmitted infections (STIs) and should be used in conjunction with condoms for safer sex practices. Additionally, there are potential risks and side effects associated with oral combined contraceptives, including an increased risk of blood clots, stroke, and heart attack, especially in women who smoke or have certain medical conditions. It is essential to consult a healthcare provider before starting any hormonal birth control method to determine if it is safe and appropriate for individual use.

Norethindrone is a synthetic form of progesterone, a female hormone that is produced naturally in the ovaries. It is used as a medication for various purposes such as:

* Preventing pregnancy when used as a birth control pill
* Treating endometriosis
* Managing symptoms associated with menopause
* Treating abnormal menstrual bleeding

Norethindrone works by thinning the lining of the uterus, preventing ovulation (the release of an egg from the ovary), and changing the cervical mucus to make it harder for sperm to reach the egg. It is important to note that norethindrone should be taken under the supervision of a healthcare provider, as it can have side effects and may interact with other medications.

Ethynodiol diacetate is a synthetic form of progestin, which is a female sex hormone. It is used in various pharmaceutical products, such as birth control pills, to prevent pregnancy by preventing ovulation and thickening cervical mucus to make it harder for sperm to reach the egg.

Ethynodiol diacetate works by mimicking the effects of natural progesterone in the body, which helps regulate the menstrual cycle and prepare the uterus for pregnancy. When used as a contraceptive, ethynodiol diacetate is often combined with estrogen to create a hormonal balance that prevents ovulation and fertilization.

It's important to note that while ethynodiol diacetate is generally considered safe and effective when taken as directed, it can have side effects and may not be suitable for everyone. Women who are pregnant, breastfeeding, or have certain medical conditions should consult with their healthcare provider before taking any medication containing this ingredient.

Spermatogenesis-blocking agents are a class of medications or substances that inhibit or block the process of spermatogenesis, which is the production of sperm in the testicles. These agents can work at various stages of spermatogenesis, including reducing the number of spermatozoa (sperm cells) or preventing the formation of mature sperm.

Examples of spermatogenesis-blocking agents include:

1. Hormonal agents: Certain hormones or hormone-like substances can interfere with the production of sperm. For example, analogs of gonadotropin-releasing hormone (GnRH) and antiandrogens can suppress the release of testosterone and other hormones necessary for spermatogenesis.
2. Alkylating agents: These are chemotherapy drugs that can damage DNA and prevent the division and multiplication of cells, including sperm cells. Examples include cyclophosphamide and busulfan.
3. Other chemicals: Certain industrial chemicals, such as ethylene glycol ethers and dibromochloropropane (DBCP), have been shown to have spermatogenesis-blocking properties.
4. Radiation therapy: High doses of radiation can also damage the testicles and inhibit sperm production.

It's important to note that spermatogenesis-blocking agents are often used for medical purposes, such as treating cancer or preventing pregnancy, but they can have significant side effects and should only be used under the guidance of a healthcare professional.

Ethinyl estradiol is a synthetic form of the hormone estrogen that is often used in various forms of hormonal contraception, such as birth control pills. It works by preventing ovulation and thickening cervical mucus to make it more difficult for sperm to reach the egg. Ethinyl estradiol may also be used in combination with other hormones to treat menopausal symptoms or hormonal disorders.

It is important to note that while ethinyl estradiol can be an effective form of hormonal therapy, it can also carry risks and side effects, such as an increased risk of blood clots, stroke, and breast cancer. As with any medication, it should only be used under the guidance and supervision of a healthcare provider.

Lynestrenol is a synthetic form of progestogen, which is a female sex hormone. It is used in various medications for different purposes, such as treating abnormal menstrual bleeding, endometriosis, and preventing premature labor. Lynestrenol works by mimicking the effects of natural progesterone in the body, helping to regulate the menstrual cycle and reduce inflammation associated with endometriosis. It is important to note that lynestrenol should only be used under the supervision of a healthcare professional, as it can have side effects and interact with other medications.

Contraceptive agents, female, are medications or devices specifically designed to prevent pregnancy in women. They work by interfering with the normal process of ovulation, fertilization, or implantation of a fertilized egg in the uterus. Some common examples of female contraceptive agents include:

1. Hormonal methods: These include combined oral contraceptives (COCs), progestin-only pills, patches, vaginal rings, and hormonal implants. They contain synthetic forms of the female hormones estrogen and/or progesterone, which work by preventing ovulation, thickening cervical mucus to make it harder for sperm to reach the egg, or thinning the lining of the uterus to prevent implantation of a fertilized egg.
2. Intrauterine devices (IUDs): These are small, T-shaped devices made of plastic or copper that are inserted into the uterus by a healthcare provider. They release hormones or copper ions that interfere with sperm movement and prevent fertilization or implantation.
3. Barrier methods: These include condoms, diaphragms, cervical caps, and sponges. They work by physically preventing sperm from reaching the egg.
4. Emergency contraception: This includes medications such as Plan B or Ella, which can be taken up to 5 days after unprotected sex to prevent pregnancy. They work by delaying ovulation or preventing fertilization of the egg.
5. Fertility awareness-based methods (FABMs): These involve tracking a woman's menstrual cycle and avoiding sexual intercourse during her fertile window. Some FABMs also involve using barrier methods during this time.

It is important to note that different contraceptive agents have varying levels of effectiveness, side effects, and risks. Women should consult with their healthcare provider to determine the best method for their individual needs and circumstances.

Ethinyl estradiol-norgestrel combination is a formulation that contains a synthetic version of the female sex hormones, estrogen (ethinyl estradiol) and progestin (norgestrel), which are used in various forms of hormonal contraception.

This combination works by preventing ovulation (the release of an egg from the ovaries), thickening cervical mucus to make it harder for sperm to reach the egg, and thinning the lining of the uterus to make it less likely for a fertilized egg to implant.

Ethinyl estradiol-norgestrel combination is commonly used in oral contraceptives (birth control pills), as well as in some forms of hormonal patches and rings. It is important to note that while this combination is highly effective at preventing pregnancy, it can also increase the risk of certain health problems, such as blood clots, stroke, and breast cancer, especially in women who smoke or have other risk factors.

Therefore, it is essential for individuals using hormonal contraceptives containing ethinyl estradiol-norgestrel combination to discuss their medical history and any potential risks with their healthcare provider before starting this form of birth control.

I'm sorry for any confusion, but "xanthurenates" is not a recognized term in medicine or physiology. It seems that you might be referring to "xanthurenic acid," which is a metabolic byproduct produced during the breakdown of the amino acid tryptophan. An accumulation of xanthurenic acid can occur due to certain genetic disorders, such as Hartnup disease or defects in the coenzyme Q10 synthesis pathway. However, without more context, it's difficult for me to provide a precise definition related to your specific question. If you could provide additional information, I would be happy to help further!

Oral hormonal contraceptives, also known as "birth control pills," are a type of medication that contains synthetic hormones (estrogen and/or progestin) that are taken by mouth to prevent pregnancy. They work by preventing ovulation (the release of an egg from the ovaries), thickening cervical mucus to make it harder for sperm to reach the egg, and thinning the lining of the uterus to make it less likely for a fertilized egg to implant.

There are several different types of oral hormonal contraceptives, including combined pills that contain both estrogen and progestin, and mini-pills that only contain progestin. These medications are usually taken daily for 21 days, followed by a seven-day break during which menstruation occurs. Some newer formulations may be taken continuously with no break.

It's important to note that while oral hormonal contraceptives are highly effective at preventing pregnancy when used correctly, they do not protect against sexually transmitted infections (STIs). Therefore, it is still important to use barrier methods of protection, such as condoms, during sexual activity to reduce the risk of STIs.

As with any medication, oral hormonal contraceptives can have side effects and may not be suitable for everyone. It's important to discuss any medical conditions, allergies, or medications you are taking with your healthcare provider before starting to take oral hormonal contraceptives.

Spermatocidal agents are substances or chemicals that have the ability to destroy or inhibit sperm cells, making them non-functional. These agents are often used in spermicides, which are a type of contraceptive method. Spermicides work by physically blocking the cervix and killing any sperm that come into contact with the spermicidal agent. Common spermatocidal agents include Nonoxynol-9, Benzalkonium chloride, and Chlorhexidine gluconate. It's important to note that while spermicides can provide some protection against pregnancy, they are not considered a highly effective form of birth control when used alone.

Contraceptive agents for males are substances or methods that are used to prevent pregnancy by reducing the likelihood of fertilization. These can include:

1. Barrier methods: Condoms, diaphragms, and spermicides create a physical barrier that prevents sperm from reaching the egg.
2. Hormonal methods: Testosterone and progestin hormone therapies can decrease sperm production and reduce fertility.
3. Intrauterine devices (IUDs) for men: These are still in the experimental stage, but they involve placing a device in the male reproductive tract to prevent sperm from reaching the female reproductive system.
4. Withdrawal method: This involves the man withdrawing his penis from the vagina before ejaculation, although this is not a highly reliable form of contraception.
5. Fertility awareness methods: These involve tracking the woman's menstrual cycle and avoiding sexual intercourse during her fertile period.
6. Sterilization: Vasectomy is a surgical procedure that blocks or cuts the vas deferens, preventing sperm from leaving the body. It is a permanent form of contraception for men.

It's important to note that no contraceptive method is 100% effective, and individuals should consult with their healthcare provider to determine which option is best for them based on their personal needs, lifestyle, and medical history.

Contraceptive devices are medical products or tools specifically designed to prevent pregnancy by blocking or interfering with the fertilization of an egg by sperm, or the implantation of a fertilized egg in the uterus. There are various types of contraceptive devices available, each with its own mechanism of action and efficacy rate. Here are some common examples:

1. Intrauterine Devices (IUDs): These are small, T-shaped devices made of plastic or copper that are inserted into the uterus by a healthcare professional. IUDs can prevent pregnancy for several years and work by affecting the movement of sperm and changing the lining of the uterus to make it less receptive to implantation.
2. Contraceptive Implants: These are small, flexible rods that are inserted under the skin of the upper arm by a healthcare professional. The implant releases hormones that prevent ovulation and thicken cervical mucus to block sperm from reaching the egg.
3. Diaphragms and Cervical Caps: These are flexible, dome-shaped devices made of silicone or rubber that are inserted into the vagina before sex. They cover the cervix and prevent sperm from entering the uterus.
4. Male and Female Condoms: These are thin sheaths made of latex, polyurethane, or other materials that are placed over the penis (male condom) or inside the vagina (female condom) during sex to prevent sperm from entering the body.
5. Spermicides: These are chemicals that kill or disable sperm and can be used alone or in combination with other contraceptive methods such as condoms, diaphragms, or cervical caps. They come in various forms, including foams, creams, gels, films, and suppositories.

It's important to note that while contraceptive devices are effective at preventing pregnancy, they do not protect against sexually transmitted infections (STIs). Using condoms is the best way to reduce the risk of STIs during sexual activity.

Contraception is the use of various devices, methods, or medications to prevent pregnancy. The term is derived from the Latin words "contra" meaning "against" and "conceptio" meaning "conception." Contraceptive methods can be broadly categorized into temporary and permanent methods. Temporary methods include barriers such as condoms, diaphragms, cervical caps, and sponges; hormonal methods like the pill, patch, ring, injection, and emergency contraception; and fertility awareness-based methods that involve tracking ovulation and avoiding intercourse during fertile periods. Permanent methods include surgical procedures such as tubal ligation for women and vasectomy for men.

The primary goal of contraception is to prevent the sperm from reaching and fertilizing the egg, thereby preventing pregnancy. However, some contraceptive methods also offer additional benefits such as reducing the risk of sexually transmitted infections (STIs) and regulating menstrual cycles. It's important to note that while contraception can prevent pregnancy, it does not protect against STIs, so using condoms is still recommended for individuals who are at risk of contracting STIs.

When choosing a contraceptive method, it's essential to consider factors such as effectiveness, safety, ease of use, cost, and personal preferences. It's also important to consult with a healthcare provider to determine the most appropriate method based on individual health history and needs.

Pyridoxine is the chemical name for Vitamin B6. According to the medical definition, Pyridoxine is a water-soluble vitamin that is part of the B-vitamin complex and is essential for the metabolism of proteins, carbohydrates, and fats. It plays a vital role in the regulation of homocysteine levels in the body, the formation of neurotransmitters such as serotonin and dopamine, and the synthesis of hemoglobin.

Pyridoxine can be found naturally in various foods, including whole grains, legumes, vegetables, nuts, seeds, meat, poultry, and fish. It is also available as a dietary supplement and may be prescribed by healthcare providers to treat or prevent certain medical conditions, such as vitamin B6 deficiency, anemia, seizures, and carpal tunnel syndrome.

Like other water-soluble vitamins, Pyridoxine cannot be stored in the body and must be replenished regularly through diet or supplementation. Excessive intake of Pyridoxine can lead to toxicity symptoms such as nerve damage, skin lesions, and light sensitivity.

Menstruation is the regular, cyclical shedding of the uterine lining (endometrium) in women and female individuals of reproductive age, accompanied by the discharge of blood and other materials from the vagina. It typically occurs every 21 to 35 days and lasts for approximately 2-7 days. This process is a part of the menstrual cycle, which is under the control of hormonal fluctuations involving follicle-stimulating hormone (FSH), luteinizing hormone (LH), estrogen, and progesterone.

The menstrual cycle can be divided into three main phases:

1. Menstruation phase: The beginning of the cycle is marked by the start of menstrual bleeding, which signals the breakdown and shedding of the endometrium due to the absence of pregnancy and low levels of estrogen and progesterone. This phase typically lasts for 2-7 days.

2. Proliferative phase: After menstruation, under the influence of rising estrogen levels, the endometrium starts to thicken and regenerate. The uterine lining becomes rich in blood vessels and glands, preparing for a potential pregnancy. This phase lasts from day 5 until around day 14 of an average 28-day cycle.

3. Secretory phase: Following ovulation (release of an egg from the ovaries), which usually occurs around day 14, increased levels of progesterone cause further thickening and maturation of the endometrium. The glands in the lining produce nutrients to support a fertilized egg. If pregnancy does not occur, both estrogen and progesterone levels will drop, leading to menstruation and the start of a new cycle.

Understanding menstruation is essential for monitoring reproductive health, identifying potential issues such as irregular periods or menstrual disorders, and planning family planning strategies.

Contraceptive devices for females refer to medical products designed to prevent pregnancy by blocking or interfering with the sperm's ability to reach and fertilize an egg. Some common examples of female contraceptive devices include:

1. Diaphragm: A shallow, flexible dome made of silicone that is inserted into the vagina before sexual intercourse to cover the cervix and prevent sperm from entering the uterus.
2. Cervical Cap: Similar to a diaphragm but smaller in size, the cervical cap fits over the cervix and creates a barrier to sperm entry.
3. Intrauterine Device (IUD): A small, T-shaped device made of plastic or copper that is inserted into the uterus by a healthcare professional. IUDs can prevent pregnancy for several years and work by changing the chemistry of the cervical mucus and uterine lining to inhibit sperm movement and implantation of a fertilized egg.
4. Contraceptive Sponge: A soft, round sponge made of polyurethane foam that contains spermicide. The sponge is inserted into the vagina before sexual intercourse and covers the cervix to prevent sperm from entering the uterus.
5. Female Condom: A thin, flexible pouch made of polyurethane or nitrile that is inserted into the vagina before sexual intercourse. The female condom creates a barrier between the sperm and the cervix, preventing pregnancy and reducing the risk of sexually transmitted infections (STIs).
6. Vaginal Ring: A flexible ring made of plastic that is inserted into the vagina for three weeks at a time to release hormones that prevent ovulation, thicken cervical mucus, and thin the lining of the uterus.
7. Contraceptive Implant: A small, flexible rod made of plastic that is implanted under the skin of the upper arm by a healthcare professional. The implant releases hormones that prevent ovulation and thicken cervical mucus to prevent pregnancy for up to three years.

It's important to note that while these contraceptive devices can be highly effective at preventing pregnancy, they do not protect against STIs. Using condoms in addition to other forms of contraception is recommended to reduce the risk of both pregnancy and STIs.

Contraception behavior refers to the actions and decisions made by individuals or couples to prevent pregnancy. This can include the use of various contraceptive methods, such as hormonal birth control (e.g., pills, patches, rings), barrier methods (e.g., condoms, diaphragms), intrauterine devices (IUDs), and natural family planning techniques (e.g., fertility awareness-based methods).

Contraception behavior can be influenced by various factors, including personal beliefs, cultural norms, relationship dynamics, access to healthcare services, and knowledge about contraceptive options. It is an important aspect of sexual and reproductive health, as it allows individuals and couples to plan their families and make informed choices about whether and when to have children.

It's worth noting that while the term "contraception behavior" typically refers to actions taken specifically to prevent pregnancy, some contraceptive methods may also provide protection against sexually transmitted infections (STIs). For example, condoms are effective at preventing both pregnancy and STIs when used consistently and correctly.

Riboflavin, also known as vitamin B2, is a water-soluble vitamin that plays a crucial role in energy production and cellular function, growth, and development. It is essential for the metabolism of carbohydrates, fats, and proteins, and it helps to maintain healthy skin, hair, and nails. Riboflavin is involved in the production of energy by acting as a coenzyme in various redox reactions. It also contributes to the maintenance of the mucous membranes of the digestive tract and promotes iron absorption.

Riboflavin can be found in a variety of foods, including milk, cheese, leafy green vegetables, liver, kidneys, legumes, yeast, mushrooms, and almonds. It is sensitive to light and heat, so exposure to these elements can lead to its degradation and loss of vitamin activity.

Deficiency in riboflavin is rare but can occur in individuals with poor dietary intake or malabsorption disorders. Symptoms of riboflavin deficiency include inflammation of the mouth and tongue, anemia, skin disorders, and neurological symptoms such as confusion and mood changes. Riboflavin supplements are available for those who have difficulty meeting their daily requirements through diet alone.

Nutrition disorders refer to conditions that result from eating, drinking, or absorbing nutrients in a way that is not consistent with human physiological needs. These disorders can manifest as both undernutrition and overnutrition. Undernutrition includes disorders such as protein-energy malnutrition, vitamin deficiencies, and mineral deficiencies, while overnutrition includes conditions such as obesity and diet-related noncommunicable diseases like diabetes, cardiovascular disease, and certain types of cancer.

Malnutrition is the broad term used to describe a state in which a person's nutrient intake is insufficient or excessive, leading to negative consequences for their health. Malnutrition can be caused by a variety of factors, including poverty, food insecurity, lack of education, cultural practices, and chronic diseases.

In addition to under- and overnutrition, disordered eating patterns such as anorexia nervosa, bulimia nervosa, binge eating disorder, and other specified feeding or eating disorders can also be considered nutrition disorders. These conditions are characterized by abnormal eating habits that can lead to serious health consequences, including malnutrition, organ damage, and mental health problems.

Overall, nutrition disorders are complex conditions that can have significant impacts on a person's physical and mental health. They require careful assessment, diagnosis, and treatment by healthcare professionals with expertise in nutrition and dietetics.

An Intrauterine Device (IUD) is a long-acting, reversible contraceptive device that is inserted into the uterus to prevent pregnancy. It is a small T-shaped piece of flexible plastic with strings attached to it for removal. There are two types of IUDs available: hormonal and copper. Hormonal IUDs release progestin, which thickens cervical mucus and thins the lining of the uterus, preventing sperm from reaching and fertilizing an egg. Copper IUDs, on the other hand, produce an inflammatory reaction in the uterus that is toxic to sperm and eggs, preventing fertilization.

IUDs are more than 99% effective at preventing pregnancy and can remain in place for several years, depending on the type. They are easily removable by a healthcare provider if a woman wants to become pregnant or choose another form of contraception. IUDs do not protect against sexually transmitted infections (STIs), so it is important to use condoms in addition to an IUD for protection against STIs.

In summary, Intrauterine Devices are small, T-shaped plastic devices that are inserted into the uterus to prevent pregnancy. They come in two types: hormonal and copper, both of which work by preventing fertilization. IUDs are highly effective, long-acting, and reversible forms of contraception.

Family planning services refer to comprehensive healthcare programs and interventions that aim to help individuals and couples prevent or achieve pregnancies, according to their desired number and spacing of children. These services typically include:

1. Counseling and education: Providing information about various contraceptive methods, their effectiveness, side effects, and appropriate use. This may also include counseling on reproductive health, sexually transmitted infections (STIs), and preconception care.
2. Contraceptive services: Making a wide range of contraceptive options available to clients, including barrier methods (condoms, diaphragms), hormonal methods (pills, patches, injectables, implants), intrauterine devices (IUDs), and permanent methods (tubal ligation, vasectomy).
3. Screening and testing: Offering STI screening and testing, as well as cervical cancer screening for eligible clients.
4. Preconception care: Providing counseling and interventions to help women achieve optimal health before becoming pregnant, including folic acid supplementation, management of chronic conditions, and avoidance of harmful substances (tobacco, alcohol, drugs).
5. Fertility services: Addressing infertility issues through diagnostic testing, counseling, and medical or surgical treatments when appropriate.
6. Menstrual regulation: Providing manual vacuum aspiration or medication to safely and effectively manage incomplete miscarriages or unwanted pregnancies within the first trimester.
7. Pregnancy options counseling: Offering unbiased information and support to help individuals make informed decisions about their pregnancy, including parenting, adoption, or abortion.
8. Community outreach and education: Engaging in community-based initiatives to increase awareness of family planning services and promote reproductive health.
9. Advocacy: Working to remove barriers to accessing family planning services, such as policy changes, reducing stigma, and increasing funding for programs.

Family planning services are an essential component of sexual and reproductive healthcare and contribute significantly to improving maternal and child health outcomes, reducing unintended pregnancies, and empowering individuals to make informed choices about their reproductive lives.

Copper is a chemical element with the symbol Cu (from Latin: *cuprum*) and atomic number 29. It is a soft, malleable, and ductile metal with very high thermal and electrical conductivity. Copper is found as a free element in nature, and it is also a constituent of many minerals such as chalcopyrite and bornite.

In the human body, copper is an essential trace element that plays a role in various physiological processes, including iron metabolism, energy production, antioxidant defense, and connective tissue synthesis. Copper is found in a variety of foods, such as shellfish, nuts, seeds, whole grains, and organ meats. The recommended daily intake of copper for adults is 900 micrograms (mcg) per day.

Copper deficiency can lead to anemia, neutropenia, impaired immune function, and abnormal bone development. Copper toxicity, on the other hand, can cause nausea, vomiting, abdominal pain, diarrhea, and in severe cases, liver damage and neurological symptoms. Therefore, it is important to maintain a balanced copper intake through diet and supplements if necessary.

Desogestrel is a synthetic form of progestin, which is a female sex hormone. It is used in various forms of hormonal contraception such as birth control pills, patches, and vaginal rings to prevent pregnancy. Desogestrel works by preventing ovulation (the release of an egg from the ovaries), thickening cervical mucus to make it harder for sperm to reach the egg, and thinning the lining of the uterus to make it less likely for a fertilized egg to implant.

Desogestrel is also used in some hormone replacement therapies (HRT) to treat symptoms of menopause such as hot flashes and vaginal dryness. It may be prescribed alone or in combination with estrogen.

Like all hormonal contraceptives, desogestrel has potential side effects, including irregular menstrual bleeding, headaches, mood changes, breast tenderness, and nausea. In rare cases, it may also increase the risk of blood clots, stroke, or heart attack. It is important to discuss the risks and benefits of desogestrel with a healthcare provider before using it.

Levonorgestrel is a synthetic form of the natural hormone progesterone, which is used in various forms of birth control and emergency contraceptives. It works by preventing ovulation (the release of an egg from the ovaries), thickening cervical mucus to make it harder for sperm to reach the egg, and thinning the lining of the uterus to make it less likely for a fertilized egg to implant.

Medically, Levonorgestrel is classified as a progestin and is available in various forms, including oral tablets, intrauterine devices (IUDs), and emergency contraceptive pills. It may also be used to treat endometriosis, irregular menstrual cycles, and heavy menstrual bleeding.

It's important to note that while Levonorgestrel is a highly effective form of birth control when used correctly, it does not protect against sexually transmitted infections (STIs). Therefore, condoms should still be used during sexual activity if there is any risk of STI transmission.

Postcoital contraceptives, also known as emergency contraception, are methods used to prevent pregnancy after sexual intercourse has already occurred. These methods are most effective when used within 24 hours of unprotected sex, but can still be effective up to 120 hours (5 days) after.

There are two main types of postcoital contraceptives:

1. Emergency contraceptive pills (ECPs): These are high-dose hormonal pills that contain levonorgestrel or ulipristal acetate. Levonorgestrel ECPs are available over-the-counter in many countries, while ulipristal acetate ECPs require a prescription.
2. Copper intrauterine device (IUD): This is a small T-shaped device made of copper that is inserted into the uterus by a healthcare provider. The copper IUD can be used as emergency contraception up to 5 days after unprotected sex, and it also provides ongoing contraception for up to 10 years.

It's important to note that postcoital contraceptives are not intended for regular use as a primary form of contraception. They should only be used in emergency situations where other methods of contraception have failed or were not used. It is also recommended to consult with a healthcare provider before using any form of emergency contraception.

Zinc is an essential mineral that is vital for the functioning of over 300 enzymes and involved in various biological processes in the human body, including protein synthesis, DNA synthesis, immune function, wound healing, and cell division. It is a component of many proteins and participates in the maintenance of structural integrity and functionality of proteins. Zinc also plays a crucial role in maintaining the sense of taste and smell.

The recommended daily intake of zinc varies depending on age, sex, and life stage. Good dietary sources of zinc include red meat, poultry, seafood, beans, nuts, dairy products, and fortified cereals. Zinc deficiency can lead to various health problems, including impaired immune function, growth retardation, and developmental delays in children. On the other hand, excessive intake of zinc can also have adverse effects on health, such as nausea, vomiting, and impaired immune function.

A contraceptive vaccine is a type of immunocontraception that uses the immune system to prevent pregnancy. It is a relatively new field of research and development, and there are currently no licensed contraceptive vaccines available on the market. However, several experimental vaccines are in various stages of preclinical and clinical testing.

Contraceptive vaccines work by stimulating the immune system to produce antibodies against specific proteins or hormones that play a critical role in reproduction. By neutralizing these targets, the vaccine can prevent fertilization or inhibit the implantation of a fertilized egg in the uterus.

For example, one approach is to develop vaccines that target the zona pellucida (ZP), a glycoprotein layer surrounding mammalian eggs. Antibodies generated against ZP proteins can prevent sperm from binding and fertilizing the egg. Another strategy is to create vaccines that generate antibodies against hormones such as human chorionic gonadotropin (hCG), a hormone produced during pregnancy. By blocking hCG, the vaccine can prevent the maintenance of pregnancy and induce a miscarriage.

While contraceptive vaccines have shown promise in preclinical studies, several challenges remain before they can be widely adopted. These include issues related to safety, efficacy, duration of protection, and public acceptance. Additionally, there are concerns about the potential for accidental cross-reactivity with other proteins or hormones, leading to unintended side effects.

Overall, contraceptive vaccines represent a promising area of research that could provide long-acting, reversible, and user-friendly contraception options in the future. However, further studies are needed to address the remaining challenges and ensure their safe and effective use.

Unplanned pregnancy is a pregnancy that is not intended or expected by the woman or couple. It is also sometimes referred to as an "unintended" or "unwanted" pregnancy. This can occur when contraceptive methods fail or are not used, or when there is a lack of knowledge about or access to effective family planning resources. Unplanned pregnancies can present various physical, emotional, and social challenges for the individuals involved, and may also have implications for public health and societal well-being. It's important to note that unplanned pregnancies can still result in wanted and loved children, but the circumstances surrounding their conception may bring additional stressors and considerations.

Reproductive sterilization is a surgical procedure that aims to prevent reproduction by making an individual unable to produce viable reproductive cells or preventing the union of sperm and egg. In males, this is often achieved through a vasectomy, which involves cutting and sealing the vas deferens, the tubes that carry sperm from the testicles to the urethra. In females, sterilization is typically performed via a procedure called tubal ligation, where the fallopian tubes are cut, tied, or sealed, preventing the egg from traveling from the ovaries to the uterus and blocking sperm from reaching the egg. These methods are considered permanent forms of contraception; however, in rare cases, reversals may be attempted with varying degrees of success.

Unwanted pregnancy is a situation where a person becomes pregnant despite not planning or desiring to conceive at that time. This can occur due to various reasons such as lack of access to effective contraception, failure of contraceptive methods, sexual assault, or a change in circumstances that makes the pregnancy untimely or inconvenient. Unwanted pregnancies can have significant physical, emotional, and socioeconomic impacts on individuals and families. It is important to address unwanted pregnancies through comprehensive sexuality education, access to affordable and effective contraception, and supportive services for those who experience unintended pregnancies.

Pregnancy is a physiological state or condition where a fertilized egg (zygote) successfully implants and grows in the uterus of a woman, leading to the development of an embryo and finally a fetus. This process typically spans approximately 40 weeks, divided into three trimesters, and culminates in childbirth. Throughout this period, numerous hormonal and physical changes occur to support the growing offspring, including uterine enlargement, breast development, and various maternal adaptations to ensure the fetus's optimal growth and well-being.

Medroxyprogesterone Acetate (MPA) is a synthetic form of the natural hormone progesterone, which is often used in various medical applications. It is a white to off-white crystalline powder, slightly soluble in water, and freely soluble in alcohol, chloroform, and methanol.

Medically, MPA is used as a prescription medication for several indications, including:

1. Contraception: As an oral contraceptive or injectable solution, it can prevent ovulation, thicken cervical mucus to make it harder for sperm to reach the egg, and alter the lining of the uterus to make it less likely for a fertilized egg to implant.
2. Hormone replacement therapy (HRT): In postmenopausal women, MPA can help manage symptoms associated with decreased estrogen levels, such as hot flashes and vaginal dryness. It may also help prevent bone loss (osteoporosis).
3. Endometrial hyperplasia: MPA can be used to treat endometrial hyperplasia, a condition where the lining of the uterus becomes too thick, which could potentially lead to cancer if left untreated. By opposing the effects of estrogen, MPA helps regulate the growth of the endometrium.
4. Gynecological disorders: MPA can be used to treat various gynecological disorders, such as irregular menstrual cycles, amenorrhea (absence of menstruation), and dysfunctional uterine bleeding.
5. Cancer treatment: In some cases, MPA may be used in conjunction with other medications to treat certain types of breast or endometrial cancer.

As with any medication, Medroxyprogesterone Acetate can have side effects and potential risks. It is essential to consult a healthcare professional for proper evaluation, dosage, and monitoring when considering this medication.

Postcoital contraception, also known as emergency contraception, refers to methods used to prevent pregnancy after sexual intercourse has already occurred. These methods are typically used in situations where regular contraception has failed or was not used, such as in cases of condom breakage or forgotten birth control pills.

There are two main types of postcoital contraception:

1. Emergency contraceptive pill (ECP): Also known as the "morning-after pill," this is a hormonal medication that can be taken up to 5 days after unprotected sex, but it is most effective when taken within 72 hours. There are two types of ECPs available: progestin-only and combined estrogen-progestin. The progestin-only pill is preferred because it has fewer side effects and is just as effective as the combined pill.
2. Copper intrauterine device (IUD): This is a small, T-shaped device made of flexible plastic and copper that is inserted into the uterus by a healthcare provider. The IUD can be inserted up to 5 days after unprotected sex to prevent pregnancy. It is the most effective form of emergency contraception available, and it also provides ongoing protection against pregnancy for up to 10 years, depending on the type of IUD.

It's important to note that postcoital contraception should not be used as a regular method of contraception, but rather as a backup in case of emergencies. It is also not effective in preventing sexually transmitted infections (STIs). Regular contraceptive methods, such as condoms and hormonal birth control, are the best ways to prevent unintended pregnancies and STIs.

An Intrauterine Device (IUD) is a small, T-shaped device that is inserted into the uterus to prevent pregnancy. The copper IUD is a type of long-acting reversible contraception (LARC) that releases copper ions, which are toxic to sperm and egg, preventing fertilization. It is one of the most effective forms of birth control available, with a failure rate of less than 1%.

The copper IUD can be used by women who have previously given birth as well as those who have not. It can be inserted up to five days after unprotected intercourse as emergency contraception to prevent pregnancy. Once inserted, the copper IUD can remain in place for up to ten years, although it can be removed at any time if a woman wants to become pregnant or for other reasons.

Copper IUDs are also used as an effective treatment for heavy menstrual bleeding and can be used to manage endometriosis-associated pain. Common side effects of copper IUDs include heavier and longer menstrual periods, cramping during insertion, and irregular periods during the first few months after insertion. However, these side effects usually subside over time.

It is important to note that while copper IUDs are highly effective at preventing pregnancy, they do not protect against sexually transmitted infections (STIs). Therefore, it is still recommended to use condoms or other barrier methods of protection during sexual activity to reduce the risk of STIs.

Norethynodrel is a synthetic progestin, which is a type of female sex hormone. It is not commonly used in modern medicine. In the past, it was used in some oral contraceptives to prevent pregnancy by inhibiting ovulation and altering the cervical mucus and endometrium. Norethynodrel is no longer widely used due to the development of newer and more effective progestins.

Induced abortion is a medical procedure that intentionally terminates a pregnancy before the fetus can survive outside the womb. It can be performed either surgically or medically through the use of medications. The timing of an induced abortion is typically based on the gestational age of the pregnancy, with different methods used at different stages.

The most common surgical procedure for induced abortion is vacuum aspiration, which is usually performed during the first trimester (up to 12-13 weeks of gestation). This procedure involves dilating the cervix and using a vacuum device to remove the pregnancy tissue from the uterus. Other surgical procedures, such as dilation and evacuation (D&E), may be used in later stages of pregnancy.

Medical abortion involves the use of medications to induce the termination of a pregnancy. The most common regimen involves the use of two drugs: mifepristone and misoprostol. Mifepristone works by blocking the action of progesterone, a hormone necessary for maintaining pregnancy. Misoprostol causes the uterus to contract and expel the pregnancy tissue. This method is typically used during the first 10 weeks of gestation.

Induced abortion is a safe and common medical procedure, with low rates of complications when performed by trained healthcare providers in appropriate settings. Access to induced abortion varies widely around the world, with some countries restricting or prohibiting the practice entirely.

Immunologic contraception refers to the use of the immune system to prevent pregnancy. This is achieved by stimulating the production of antibodies against specific proteins or hormones that are essential for fertilization and implantation of a fertilized egg in the uterus. The most well-known example of immunologic contraception is the development of a vaccine that would induce an immune response against human chorionic gonadotropin (hCG), a hormone produced during pregnancy. By neutralizing hCG, the immune system could prevent the establishment and maintenance of pregnancy. However, this approach is still in the experimental stage and has not yet been approved for use in humans.

Progestins are a class of steroid hormones that are similar to progesterone, a natural hormone produced by the ovaries during the menstrual cycle and pregnancy. They are often used in hormonal contraceptives, such as birth control pills, shots, and implants, to prevent ovulation and thicken the cervical mucus, making it more difficult for sperm to reach the egg. Progestins are also used in menopausal hormone therapy to alleviate symptoms of menopause, such as hot flashes and vaginal dryness. Additionally, progestins may be used to treat endometriosis, uterine fibroids, and breast cancer. Different types of progestins have varying properties and may be more suitable for certain indications or have different side effect profiles.

Norpregnenes are a class of steroids that are produced by the metabolism of progesterone and other pregnanes. They are characterized by the absence of a double bond between carbons 4 and 5, and the presence of a ketone group at carbon 3. Some examples of norpregnenes include dehydroepiandrosterone (DHEA), androstenedione, and pregnenolone. These steroids are important intermediates in the biosynthesis of various hormones, including cortisol, aldosterone, androgens, and estrogens. They play a role in various physiological processes such as sexual development, immune function, and stress response.

Oral contraceptives, sequential, are a type of birth control medication that involves taking two different hormonal preparations in a specific sequence to mimic the natural menstrual cycle. The first hormone preparation contains estrogen and is taken for 16-21 days, followed by a second hormone preparation containing both estrogen and progestin for 7 days. This regimen causes the lining of the uterus to thin, making it less likely for a fertilized egg to implant, and also thickens cervical mucus, which can prevent sperm from reaching the egg. Sequential oral contraceptives are not commonly used in the United States due to their higher risk of side effects compared to other forms of oral contraceptives.

Postcoital hormonal contraceptives, also known as emergency contraceptives, are methods used to prevent pregnancy after sexual intercourse has already occurred. These contraceptives contain hormones and are intended for use in emergency situations where regular contraception has failed or was not used, such as in cases of condom breakage or unprotected sex.

The most common type of postcoital hormonal contraceptive is the emergency contraceptive pill (ECP), which contains a high dose of synthetic progestin or a combination of progestin and estrogen. The ECP works by preventing ovulation, inhibiting fertilization, or altering the lining of the uterus to prevent implantation of a fertilized egg.

The ECP is most effective when taken as soon as possible after unprotected sex, ideally within 72 hours, but may still be effective up to 120 hours (5 days) after intercourse. However, the effectiveness of the ECP decreases over time, and it is not as effective as regular methods of contraception.

It's important to note that postcoital hormonal contraceptives are not intended for routine use as a primary method of contraception and should only be used in emergency situations. They do not protect against sexually transmitted infections (STIs) and should not be used as a substitute for regular condom use or other forms of protection.

If you have any concerns about postcoital hormonal contraceptives or need advice on the best method of contraception for you, it's important to speak with a healthcare provider.

Tubal sterilization, also known as female sterilization or tubal ligation, is a permanent form of birth control for women. It involves blocking, sealing, or removing the fallopian tubes, which prevents the sperm from reaching and fertilizing the egg. This procedure can be performed surgically through various methods such as cutting and tying the tubes, using clips or rings to block them, or removing a portion of the tube (known as a partial salpingectomy). Tubal sterilization is considered a highly effective form of contraception with a low failure rate. However, it does not protect against sexually transmitted infections and should be combined with condom use for that purpose. It's important to note that tubal sterilization is a permanent procedure and cannot be easily reversed.

Fertility is the natural ability to conceive or to cause conception of offspring. In humans, it is the capacity of a woman and a man to reproduce through sexual reproduction. For women, fertility usually takes place during their reproductive years, which is from adolescence until menopause. A woman's fertility depends on various factors including her age, overall health, and the health of her reproductive system.

For men, fertility can be affected by a variety of factors such as age, genetics, general health, sexual function, and environmental factors that may affect sperm production or quality. Factors that can negatively impact male fertility include exposure to certain chemicals, radiation, smoking, alcohol consumption, drug use, and sexually transmitted infections (STIs).

Infertility is a common medical condition affecting about 10-15% of couples trying to conceive. Infertility can be primary or secondary. Primary infertility refers to the inability to conceive after one year of unprotected sexual intercourse, while secondary infertility refers to the inability to conceive following a previous pregnancy.

Infertility can be treated with various medical and surgical interventions depending on the underlying cause. These may include medications to stimulate ovulation, intrauterine insemination (IUI), in vitro fertilization (IVF), or surgery to correct anatomical abnormalities.

The menstrual cycle is a series of natural changes that occur in the female reproductive system over an approximate 28-day interval, marking the body's preparation for potential pregnancy. It involves the interplay of hormones that regulate the growth and disintegration of the uterine lining (endometrium) and the release of an egg (ovulation) from the ovaries.

The menstrual cycle can be divided into three main phases:

1. Menstrual phase: The cycle begins with the onset of menstruation, where the thickened uterine lining is shed through the vagina, lasting typically for 3-7 days. This shedding occurs due to a decrease in estrogen and progesterone levels, which are hormones essential for maintaining the endometrium during the previous cycle.

2. Follicular phase: After menstruation, the follicular phase commences with the pituitary gland releasing follicle-stimulating hormone (FSH). FSH stimulates the growth of several ovarian follicles, each containing an immature egg. One dominant follicle usually becomes selected to mature and release an egg during ovulation. Estrogen levels rise as the dominant follicle grows, causing the endometrium to thicken in preparation for a potential pregnancy.

3. Luteal phase: Following ovulation, the ruptured follicle transforms into the corpus luteum, which produces progesterone and estrogen to further support the endometrial thickening. If fertilization does not occur within approximately 24 hours after ovulation, the corpus luteum will degenerate, leading to a decline in hormone levels. This drop triggers the onset of menstruation, initiating a new menstrual cycle.

Understanding the menstrual cycle is crucial for monitoring reproductive health and planning or preventing pregnancies. Variations in cycle length and symptoms are common among women, but persistent irregularities may indicate underlying medical conditions requiring further evaluation by a healthcare professional.

"Health Knowledge, Attitudes, and Practices" (HKAP) is a term used in public health to refer to the knowledge, beliefs, assumptions, and behaviors that individuals possess or engage in that are related to health. Here's a brief definition of each component:

1. Health Knowledge: Refers to the factual information and understanding that individuals have about various health-related topics, such as anatomy, physiology, disease processes, and healthy behaviors.
2. Attitudes: Represent the positive or negative evaluations, feelings, or dispositions that people hold towards certain health issues, practices, or services. These attitudes can influence their willingness to adopt and maintain healthy behaviors.
3. Practices: Encompass the specific actions or habits that individuals engage in related to their health, such as dietary choices, exercise routines, hygiene practices, and use of healthcare services.

HKAP is a multidimensional concept that helps public health professionals understand and address various factors influencing individual and community health outcomes. By assessing and addressing knowledge gaps, negative attitudes, or unhealthy practices, interventions can be designed to promote positive behavior change and improve overall health status.

In medical terms, parity refers to the number of times a woman has given birth to a viable fetus, usually defined as a pregnancy that reaches at least 20 weeks' gestation. It is often used in obstetrics and gynecology to describe a woman's childbearing history and to assess potential risks associated with childbirth.

Parity is typically categorized as follows:

* Nulliparous: A woman who has never given birth to a viable fetus.
* Primiparous: A woman who has given birth to one viable fetus.
* Multiparous: A woman who has given birth to more than one viable fetus.

In some cases, parity may also consider the number of pregnancies that resulted in stillbirths or miscarriages, although this is not always the case. It's important to note that parity does not necessarily reflect the total number of pregnancies a woman has had, only those that resulted in viable births.

Female genitalia refer to the reproductive and sexual organs located in the female pelvic region. They are primarily involved in reproduction, menstruation, and sexual activity. The external female genitalia, also known as the vulva, include the mons pubis, labia majora, labia minora, clitoris, and the external openings of the urethra and vagina. The internal female genitalia consist of the vagina, cervix, uterus, fallopian tubes, and ovaries. These structures work together to facilitate menstruation, fertilization, pregnancy, and childbirth.

Androstenes are a group of steroidal compounds that are produced and released by the human body. They are classified as steroids because they contain a characteristic carbon skeleton, called the sterane ring, which consists of four fused rings arranged in a specific structure. Androstenes are derived from cholesterol and are synthesized in the gonads (testes and ovaries), adrenal glands, and other tissues.

The term "androstene" refers specifically to compounds that contain a double bond between the 5th and 6th carbon atoms in the sterane ring. This double bond gives these compounds their characteristic chemical properties and distinguishes them from other steroidal compounds.

Androstenes are important in human physiology because they serve as precursors to the synthesis of sex hormones, such as testosterone and estrogen. They also have been found to play a role in the regulation of various bodily functions, including sexual behavior, mood, and cognition.

Some examples of androstenes include androstenedione, which is a precursor to both testosterone and estrogen; androstenediol, which can be converted into either testosterone or estrogen; and androsterone, which is a weak androgen that is produced in the body as a metabolite of testosterone.

It's worth noting that androstenes are sometimes referred to as "pheromones" because they have been found to play a role in chemical communication between individuals of the same species. However, this use of the term "pheromone" is controversial and not universally accepted, as it has been difficult to demonstrate conclusively that humans communicate using chemical signals in the same way that many other animals do.

Progesterone congeners refer to synthetic or naturally occurring compounds that are structurally similar to progesterone, a steroid hormone involved in the menstrual cycle, pregnancy, and embryogenesis. These compounds have similar chemical structures to progesterone and may exhibit similar physiological activities, although they can also have unique properties and uses. Examples of progesterone congeners include various synthetic progestins used in hormonal contraceptives and other medical treatments.

An intrauterine device (IUD) is a small, T-shaped birth control device that is inserted into the uterus to prevent pregnancy. A medicated IUD is a type of IUD that contains hormones, which are released slowly over time to provide additional benefits beyond just contraception.

There are two types of medicated IUDs available in the US market: levonorgestrel-releasing intrauterine system (LNG-IUS) and the copper intrauterine device (Cu-IUD). The LNG-IUS releases a progestin hormone called levonorgestrel, which thickens cervical mucus to prevent sperm from reaching the egg, thins the lining of the uterus to make it less likely for a fertilized egg to implant, and can also inhibit ovulation in some women. The Cu-IUD is non-hormonal and works by releasing copper ions that create a toxic environment for sperm, preventing them from reaching the egg.

Medicated IUDs are highly effective at preventing pregnancy, with typical use failure rates of less than 1% per year. They can remain in place for several years, depending on the brand, and can be removed at any time by a healthcare provider if a woman wants to become pregnant or experience side effects. Common side effects of medicated IUDs may include irregular menstrual bleeding, cramping, and spotting between periods, although these tend to improve over time.

Contraceptive devices for males are designed to prevent pregnancy by blocking, killing, or inhibiting the movement of sperm. These devices include:

1. Condoms: Thin sheaths made of latex, polyurethane, or polyisoprene that fit over the penis during sexual intercourse to collect semen and prevent it from entering the partner's body. They also provide protection against sexually transmitted infections (STIs).
2. Diaphragms: Soft, dome-shaped rubber devices fitted to cover the cervix inside the vagina. When used with spermicides, they can help prevent pregnancy by blocking the entry of sperm into the uterus.
3. Cervical Cap: A smaller, thimble-like cup made of silicone or latex that fits over the cervix to block sperm from entering the uterus. It is often used with spermicides for added effectiveness.
4. Spermicides: Chemicals that kill or immobilize sperm. They come in various forms, such as foams, creams, gels, films, and suppositories, and can be used alone or in combination with other barrier methods like condoms, diaphragms, or cervical caps.
5. Vasectomy: A surgical procedure for male sterilization that involves cutting and sealing the vas deferens, the tubes that carry sperm from the testicles to the prostate gland. This prevents sperm from mixing with semen during ejaculation. Although vasectomies are considered permanent, in some cases, they can be reversed through surgery or other medical procedures.

It is important to note that while these contraceptive devices can significantly reduce the risk of pregnancy, they may not provide complete protection against STIs. Using multiple methods, like condoms and spermicides together, can increase overall effectiveness in preventing both pregnancy and STIs. Always consult a healthcare professional for personalized advice on contraceptive options.

Menstruation disturbances, also known as menstrual disorders, refer to any irregularities or abnormalities in a woman's menstrual cycle. These disturbances can manifest in various ways, including:

1. Amenorrhea: The absence of menstrual periods for three consecutive cycles or more in women of reproductive age.
2. Oligomenorrhea: Infrequent or light menstrual periods that occur at intervals greater than 35 days.
3. Dysmenorrhea: Painful menstruation, often accompanied by cramping, pelvic pain, and other symptoms that can interfere with daily activities.
4. Menorrhagia: Heavy or prolonged menstrual periods that last longer than seven days or result in excessive blood loss, leading to anemia or other health complications.
5. Polymenorrhea: Abnormally frequent menstrual periods that occur at intervals of 21 days or less.
6. Metrorrhagia: Irregular and unpredictable vaginal bleeding between expected menstrual periods, which can be caused by various factors such as hormonal imbalances, infections, or structural abnormalities.

Menstruation disturbances can have significant impacts on a woman's quality of life, fertility, and overall health. They may result from various underlying conditions, including hormonal imbalances, polycystic ovary syndrome (PCOS), thyroid disorders, uterine fibroids, endometriosis, or sexually transmitted infections. Proper diagnosis and treatment of the underlying cause are essential for managing menstruation disturbances effectively.

A drug implant is a medical device that is specially designed to provide controlled release of a medication into the body over an extended period of time. Drug implants can be placed under the skin or in various body cavities, depending on the specific medical condition being treated. They are often used when other methods of administering medication, such as oral pills or injections, are not effective or practical.

Drug implants come in various forms, including rods, pellets, and small capsules. The medication is contained within the device and is released slowly over time, either through diffusion or erosion of the implant material. This allows for a steady concentration of the drug to be maintained in the body, which can help to improve treatment outcomes and reduce side effects.

Some common examples of drug implants include:

1. Hormonal implants: These are small rods that are inserted under the skin of the upper arm and release hormones such as progestin or estrogen over a period of several years. They are often used for birth control or to treat conditions such as endometriosis or uterine fibroids.
2. Intraocular implants: These are small devices that are placed in the eye during surgery to release medication directly into the eye. They are often used to treat conditions such as age-related macular degeneration or diabetic retinopathy.
3. Bone cement implants: These are specially formulated cements that contain antibiotics and are used to fill bone defects or joint spaces during surgery. The antibiotics are released slowly over time, helping to prevent infection.
4. Implantable pumps: These are small devices that are placed under the skin and deliver medication directly into a specific body cavity, such as the spinal cord or the peritoneal cavity. They are often used to treat chronic pain or cancer.

Overall, drug implants offer several advantages over other methods of administering medication, including improved compliance, reduced side effects, and more consistent drug levels in the body. However, they may also have some disadvantages, such as the need for surgical placement and the potential for infection or other complications. As with any medical treatment, it is important to discuss the risks and benefits of drug implants with a healthcare provider.

Pregnancy in adolescence, also known as teenage pregnancy, refers to a pregnancy that occurs in females under the age of 20. This can be further categorized into early adolescent pregnancy (occurring between ages 10-14), middle adolescent pregnancy (occurring between ages 15-17), and late adolescent pregnancy (occurring between ages 18-19). Teenage pregnancy is associated with higher risks of complications for both the mother and the baby, including preterm birth, low birth weight, and increased risk of neonatal mortality. Additionally, teenage mothers are more likely to drop out of school and face socioeconomic challenges.

Sexual behavior refers to any physical or emotional interaction that has the potential to lead to sexual arousal and/or satisfaction. This can include a wide range of activities, such as kissing, touching, fondling, oral sex, vaginal sex, anal sex, and masturbation. It can also involve the use of sexual aids, such as vibrators or pornography.

Sexual behavior is influenced by a variety of factors, including biological, psychological, social, and cultural influences. It is an important aspect of human development and relationships, and it is essential to healthy sexual functioning and satisfaction. However, sexual behavior can also be associated with risks, such as sexually transmitted infections (STIs) and unintended pregnancies, and it is important for individuals to engage in safe and responsible sexual practices.

It's important to note that sexual behavior can vary widely among individuals and cultures, and what may be considered normal or acceptable in one culture or context may not be in another. It's also important to recognize that all individuals have the right to make informed decisions about their own sexual behavior and to have their sexual rights and autonomy respected.

Megestrol is a synthetic progestin, which is a type of female hormone. It is used to treat certain types of cancer, such as breast cancer and endometrial cancer, in postmenopausal women. Megestrol works by blocking the effects of estrogen, a female hormone that can promote the growth of some breast and endometrial cancers.

Megestrol is also used to treat anorexia (loss of appetite) and cachexia (wasting syndrome) in people with AIDS or cancer. It works by increasing appetite and promoting weight gain.

Megestrol is available as a tablet or a suspension that is taken by mouth, usually two to four times a day. The dosage depends on the condition being treated and the individual patient's response to therapy. Common side effects of megestrol include nausea, vomiting, diarrhea, dizziness, headache, breast tenderness, and changes in menstrual periods.

It is important to note that megestrol can cause serious side effects, such as blood clots, fluid retention, and increased risk of certain types of infections. Patients should discuss the risks and benefits of megestrol therapy with their healthcare provider before starting treatment.

Sex education is a systematic instruction or information regarding human sexuality, including human reproduction, sexual anatomy and physiology, sexually transmitted infections, sexual activity, sexual orientation, emotional relations, reproductive health, and safe sex, among other topics. It is usually taught in schools but can also be provided by healthcare professionals, parents, or community organizations. The aim of sex education is to equip individuals with the knowledge and skills necessary to make informed decisions about their sexual health and relationships while promoting responsible and respectful attitudes towards sexuality.

Postcoital contraceptives, also known as emergency contraceptives, are methods used to prevent pregnancy after sexual intercourse. The synthetic postcoital contraceptive is a type of emergency contraception that contains synthetic hormones, such as levonorgestrel or ulipristal acetate. These hormones work by preventing ovulation, inhibiting fertilization, or altering the lining of the uterus to prevent implantation of a fertilized egg.

The most common synthetic postcoital contraceptive is the levonorgestrel emergency contraceptive pill (LNG-ECP), which contains a high dose of the synthetic hormone levonorgestrel. It is usually taken as a single dose within 72 hours (3 days) of unprotected sexual intercourse, but it is most effective when taken as soon as possible after intercourse.

Another synthetic postcoital contraceptive is ulipristal acetate, which is also taken as a single dose but within 120 hours (5 days) of unprotected sexual intercourse. Ulipristal acetate works by delaying ovulation and preventing the fertilized egg from implanting in the uterus.

It's important to note that synthetic postcoital contraceptives are not intended for regular use as a primary form of birth control, but rather as an emergency measure to prevent pregnancy after unprotected sexual intercourse or contraceptive failure. They should be used under the guidance of a healthcare provider and should not be used in place of regular contraception.

Medical Definition:

"Risk factors" are any attribute, characteristic or exposure of an individual that increases the likelihood of developing a disease or injury. They can be divided into modifiable and non-modifiable risk factors. Modifiable risk factors are those that can be changed through lifestyle choices or medical treatment, while non-modifiable risk factors are inherent traits such as age, gender, or genetic predisposition. Examples of modifiable risk factors include smoking, alcohol consumption, physical inactivity, and unhealthy diet, while non-modifiable risk factors include age, sex, and family history. It is important to note that having a risk factor does not guarantee that a person will develop the disease, but rather indicates an increased susceptibility.

A condom is a thin sheath that covers the penis during sexual intercourse. It is made of materials such as latex, polyurethane, or lambskin and is used as a barrier method to prevent pregnancy and sexually transmitted infections (STIs). Condoms work by collecting semen when the man ejaculates, preventing it from entering the woman's body. They come in various sizes, shapes, textures, and flavors to suit individual preferences. It is important to use condoms correctly and consistently to maximize their effectiveness.

Estrogens are a group of steroid hormones that are primarily responsible for the development and regulation of female sexual characteristics and reproductive functions. They are also present in lower levels in males. The main estrogen hormone is estradiol, which plays a key role in promoting the growth and development of the female reproductive system, including the uterus, fallopian tubes, and breasts. Estrogens also help regulate the menstrual cycle, maintain bone density, and have important effects on the cardiovascular system, skin, hair, and cognitive function.

Estrogens are produced primarily by the ovaries in women, but they can also be produced in smaller amounts by the adrenal glands and fat cells. In men, estrogens are produced from the conversion of testosterone, the primary male sex hormone, through a process called aromatization.

Estrogen levels vary throughout a woman's life, with higher levels during reproductive years and lower levels after menopause. Estrogen therapy is sometimes used to treat symptoms of menopause, such as hot flashes and vaginal dryness, or to prevent osteoporosis in postmenopausal women. However, estrogen therapy also carries risks, including an increased risk of certain cancers, blood clots, and stroke, so it is typically recommended only for women who have a high risk of these conditions.

"Sex factors" is a term used in medicine and epidemiology to refer to the differences in disease incidence, prevalence, or response to treatment that are observed between males and females. These differences can be attributed to biological differences such as genetics, hormones, and anatomy, as well as social and cultural factors related to gender.

For example, some conditions such as autoimmune diseases, depression, and osteoporosis are more common in women, while others such as cardiovascular disease and certain types of cancer are more prevalent in men. Additionally, sex differences have been observed in the effectiveness and side effects of various medications and treatments.

It is important to consider sex factors in medical research and clinical practice to ensure that patients receive appropriate and effective care.

"Age factors" refer to the effects, changes, or differences that age can have on various aspects of health, disease, and medical care. These factors can encompass a wide range of issues, including:

1. Physiological changes: As people age, their bodies undergo numerous physical changes that can affect how they respond to medications, illnesses, and medical procedures. For example, older adults may be more sensitive to certain drugs or have weaker immune systems, making them more susceptible to infections.
2. Chronic conditions: Age is a significant risk factor for many chronic diseases, such as heart disease, diabetes, cancer, and arthritis. As a result, age-related medical issues are common and can impact treatment decisions and outcomes.
3. Cognitive decline: Aging can also lead to cognitive changes, including memory loss and decreased decision-making abilities. These changes can affect a person's ability to understand and comply with medical instructions, leading to potential complications in their care.
4. Functional limitations: Older adults may experience physical limitations that impact their mobility, strength, and balance, increasing the risk of falls and other injuries. These limitations can also make it more challenging for them to perform daily activities, such as bathing, dressing, or cooking.
5. Social determinants: Age-related factors, such as social isolation, poverty, and lack of access to transportation, can impact a person's ability to obtain necessary medical care and affect their overall health outcomes.

Understanding age factors is critical for healthcare providers to deliver high-quality, patient-centered care that addresses the unique needs and challenges of older adults. By taking these factors into account, healthcare providers can develop personalized treatment plans that consider a person's age, physical condition, cognitive abilities, and social circumstances.

"Sex characteristics" refer to the anatomical, chromosomal, and genetic features that define males and females. These include both primary sex characteristics (such as reproductive organs like ovaries or testes) and secondary sex characteristics (such as breasts or facial hair) that typically develop during puberty. Sex characteristics are primarily determined by the presence of either X or Y chromosomes, with XX individuals usually developing as females and XY individuals usually developing as males, although variations and exceptions to this rule do occur.

Ovulation inhibition is a term used in reproductive medicine to describe the prevention or delay of ovulation, which is the release of a mature egg from the ovaries during the menstrual cycle. This can be achieved through various means, such as hormonal contraceptives (birth control pills, patches, rings), injectable hormones, or intrauterine devices (IUDs) that release hormones.

Hormonal contraceptives typically contain synthetic versions of the hormones estrogen and progestin, which work together to inhibit the natural hormonal signals that trigger ovulation. By suppressing the surge in luteinizing hormone (LH) and follicle-stimulating hormone (FSH), these methods prevent the development and release of a mature egg from the ovaries.

In addition to preventing ovulation, hormonal contraceptives can also thicken cervical mucus, making it more difficult for sperm to reach the egg, and thin the lining of the uterus, reducing the likelihood of implantation in case fertilization does occur. It is important to note that while ovulation inhibition is a reliable method of birth control, it may not provide protection against sexually transmitted infections (STIs).

Medroxyprogesterone is a synthetic form of the natural hormone progesterone, which is a female sex hormone produced by the corpus luteum during the menstrual cycle and by the placenta during pregnancy. As a medication, medroxyprogesterone is used to treat a variety of conditions, including:

* Abnormal menstrual bleeding
* Endometrial hyperplasia (overgrowth of the lining of the uterus)
* Contraception (birth control)
* Hormone replacement therapy in postmenopausal women
* Prevention of breast cancer in high-risk women
* Treatment of certain types of cancer, such as endometrial and renal cancers

Medroxyprogesterone works by binding to progesterone receptors in the body, which helps to regulate the menstrual cycle, maintain pregnancy, and prevent the growth of some types of cancer. It is available in various forms, including tablets, injectable solutions, and depot suspensions for intramuscular injection.

It's important to note that medroxyprogesterone can have significant side effects, and its use should be monitored by a healthcare provider. Women who are pregnant or breastfeeding should not take medroxyprogesterone, and it may interact with other medications, so it is important to inform your doctor of all medications you are taking before starting medroxyprogesterone.

Norpregnadienes are a type of steroid hormone that are structurally similar to progesterone, but with certain chemical groups (such as the methyl group at C10) removed. They are formed through the metabolism of certain steroid hormones and can be further metabolized into other compounds.

Norpregnadienes have been studied for their potential role in various physiological processes, including the regulation of reproductive function and the development of certain diseases such as cancer. However, more research is needed to fully understand their functions and clinical significance.

A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. It allows for a controlled release of medication over a certain period, typically lasting for 1-3 days. This method of administration can offer advantages such as avoiding gastrointestinal side effects, enabling self-administration, and providing consistent therapeutic drug levels. Common examples of transdermal patches include those used to deliver medications like nicotine, fentanyl, estradiol, and various pain-relieving agents.

Estradiol congeners refer to chemical compounds that are structurally similar to estradiol, which is the most potent and prevalent form of estrogen in humans. Estradiol congeners can be naturally occurring or synthetic and may have similar or different biological activities compared to estradiol.

These compounds can be found in various sources, including plants, animals, and industrial products. Some estradiol congeners are used in pharmaceuticals as hormone replacement therapies, while others are considered environmental pollutants and may have endocrine-disrupting effects on wildlife and humans.

Examples of estradiol congeners include:

1. Estrone (E1): a weak estrogen that is produced in the body from estradiol and is also found in some plants.
2. Estriol (E3): a weaker estrogen that is produced in large quantities during pregnancy.
3. Diethylstilbestrol (DES): a synthetic estrogen that was prescribed to pregnant women from the 1940s to the 1970s to prevent miscarriage, but was later found to have serious health effects on their offspring.
4. Zeranol: a synthetic non-steroidal estrogen used as a growth promoter in livestock.
5. Bisphenol A (BPA): a chemical used in the production of plastics and epoxy resins, which has been shown to have weak estrogenic activity and may disrupt the endocrine system.

Ethisterone is a synthetic steroid hormone that has progestogenic and androgenic activity. Its chemical name is pregneninolone acetate, and it is used in some medical treatments, such as for certain types of breast cancer and for the treatment of menstrual disorders. It is not commonly used today due to the availability of other hormonal therapies with more favorable side effect profiles. As with any medication, it should only be used under the guidance of a healthcare professional.

Uterine hemorrhage, also known as uterine bleeding or gynecological bleeding, is an abnormal loss of blood from the uterus. It can occur in various clinical settings such as menstruation (known as menorrhagia), postpartum period (postpartum hemorrhage), or in non-pregnant women (dysfunctional uterine bleeding). The bleeding may be light to heavy, intermittent or continuous, and can be accompanied by symptoms such as pain, dizziness, or fainting. Uterine hemorrhage is a common gynecological problem that can have various underlying causes, including hormonal imbalances, structural abnormalities, coagulopathies, and malignancies. It is important to seek medical attention if experiencing heavy or prolonged uterine bleeding to determine the cause and receive appropriate treatment.

A questionnaire in the medical context is a standardized, systematic, and structured tool used to gather information from individuals regarding their symptoms, medical history, lifestyle, or other health-related factors. It typically consists of a series of written questions that can be either self-administered or administered by an interviewer. Questionnaires are widely used in various areas of healthcare, including clinical research, epidemiological studies, patient care, and health services evaluation to collect data that can inform diagnosis, treatment planning, and population health management. They provide a consistent and organized method for obtaining information from large groups or individual patients, helping to ensure accurate and comprehensive data collection while minimizing bias and variability in the information gathered.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

Metrorrhagia is defined as uterine bleeding that occurs at irregular intervals, particularly between expected menstrual periods. It can also be described as abnormal vaginal bleeding that is not related to the regular menstrual cycle. The amount of bleeding can vary from light spotting to heavy flow.

Metrorrhagia is different from menorrhagia, which refers to excessive or prolonged menstrual bleeding during the menstrual period. Metrorrhagia can be caused by various factors, including hormonal imbalances, uterine fibroids, polyps, endometrial hyperplasia, infection, pregnancy complications, and certain medications or medical conditions.

It is essential to consult a healthcare provider if you experience any abnormal vaginal bleeding to determine the underlying cause and receive appropriate treatment.

Female condoms are a form of barrier contraception that provides protection against sexually transmitted infections (STIs) and pregnancy. They are made of soft, flexible nitrile rubber sheath that is inserted into the vagina before sexual intercourse. The closed end of the sheath covers the cervix, while the open end remains outside the vagina, covering the labia.

The female condom works by providing a physical barrier that prevents semen from entering the vagina and coming into contact with the cervix and internal reproductive organs. This helps to prevent pregnancy and also reduces the risk of STI transmission by preventing direct genital-to-genital contact.

Female condoms are an important option for individuals who cannot or do not wish to use male condoms, as they offer similar protection against STIs and pregnancy. They can be inserted up to eight hours before sexual intercourse, providing greater spontaneity and convenience compared to male condoms. Additionally, female condoms may be used during anal sex to reduce the risk of STI transmission.

It is important to note that female condoms should not be used in conjunction with male condoms, as this can increase friction and cause either condom to break or slip off. Proper use and handling of female condoms are essential for ensuring their effectiveness and preventing accidental pregnancy or STI transmission.

Coitus is the medical term for sexual intercourse, which is typically defined as the act of inserting the penis into the vagina for the purpose of sexual pleasure, reproduction, or both. It often involves rhythmic thrusting and movement, and can lead to orgasm in both males and females. Coitus may also be referred to as vaginal sex or penetrative sex.

It's important to note that there are many ways to engage in sexual activity beyond coitus, including oral sex, manual stimulation, and using sex toys. All of these forms of sexual expression can be healthy and normal when practiced safely and with consent.

Sexual behavior in animals refers to a variety of behaviors related to reproduction and mating that occur between members of the same species. These behaviors can include courtship displays, mating rituals, and various physical acts. The specific forms of sexual behavior displayed by a given species are influenced by a combination of genetic, hormonal, and environmental factors.

In some animals, sexual behavior is closely tied to reproductive cycles and may only occur during certain times of the year or under specific conditions. In other species, sexual behavior may be more frequent and less closely tied to reproduction, serving instead as a means of social bonding or communication.

It's important to note that while humans are animals, the term "sexual behavior" is often used in a more specific sense to refer to sexual activities between human beings. The study of sexual behavior in animals is an important area of research within the field of animal behavior and can provide insights into the evolutionary origins of human sexual behavior as well as the underlying mechanisms that drive it.

Reproduction, in the context of biology and medicine, refers to the process by which organisms produce offspring. It is a complex process that involves the creation, development, and growth of new individuals from parent organisms. In sexual reproduction, this process typically involves the combination of genetic material from two parents through the fusion of gametes (sex cells) such as sperm and egg cells. This results in the formation of a zygote, which then develops into a new individual with a unique genetic makeup.

In contrast, asexual reproduction does not involve the fusion of gametes and can occur through various mechanisms such as budding, fragmentation, or parthenogenesis. Asexual reproduction results in offspring that are genetically identical to the parent organism.

Reproduction is a fundamental process that ensures the survival and continuation of species over time. It is also an area of active research in fields such as reproductive medicine, where scientists and clinicians work to understand and address issues related to human fertility, contraception, and genetic disorders.

A case-control study is an observational research design used to identify risk factors or causes of a disease or health outcome. In this type of study, individuals with the disease or condition (cases) are compared with similar individuals who do not have the disease or condition (controls). The exposure history or other characteristics of interest are then compared between the two groups to determine if there is an association between the exposure and the disease.

Case-control studies are often used when it is not feasible or ethical to conduct a randomized controlled trial, as they can provide valuable insights into potential causes of diseases or health outcomes in a relatively short period of time and at a lower cost than other study designs. However, because case-control studies rely on retrospective data collection, they are subject to biases such as recall bias and selection bias, which can affect the validity of the results. Therefore, it is important to carefully design and conduct case-control studies to minimize these potential sources of bias.

Logistic models, specifically logistic regression models, are a type of statistical analysis used in medical and epidemiological research to identify the relationship between the risk of a certain health outcome or disease (dependent variable) and one or more independent variables, such as demographic factors, exposure variables, or other clinical measurements.

In contrast to linear regression models, logistic regression models are used when the dependent variable is binary or dichotomous in nature, meaning it can only take on two values, such as "disease present" or "disease absent." The model uses a logistic function to estimate the probability of the outcome based on the independent variables.

Logistic regression models are useful for identifying risk factors and estimating the strength of associations between exposures and health outcomes, adjusting for potential confounders, and predicting the probability of an outcome given certain values of the independent variables. They can also be used to develop clinical prediction rules or scores that can aid in decision-making and patient care.

Sexually Transmitted Diseases (STDs), also known as Sexually Transmitted Infections (STIs), are a group of diseases or infections that spread primarily through sexual contact, including vaginal, oral, and anal sex. They can also be transmitted through non-sexual means such as mother-to-child transmission during childbirth or breastfeeding, or via shared needles.

STDs can cause a range of symptoms, from mild to severe, and some may not show any symptoms at all. Common STDs include chlamydia, gonorrhea, syphilis, HIV/AIDS, human papillomavirus (HPV), herpes simplex virus (HSV), hepatitis B, and pubic lice.

If left untreated, some STDs can lead to serious health complications, such as infertility, organ damage, blindness, or even death. It is important to practice safe sex and get regular screenings for STDs if you are sexually active, especially if you have multiple partners or engage in high-risk behaviors.

Preventive measures include using barrier methods of protection, such as condoms, dental dams, and female condoms, getting vaccinated against HPV and hepatitis B, and limiting the number of sexual partners. If you suspect that you may have an STD, it is important to seek medical attention promptly for diagnosis and treatment.

Nonoxynol is a surfactant, or surface-active agent, that has been used in various medical and consumer products. It is a type of chemical compound known as a polyoxyethylene alkyl ether, which means it contains a hydrophilic (water-attracting) ethylene oxide group and a hydrophobic (water-repelling) alkyl group.

In the medical field, Nonoxynol has been used as a spermicide in various forms of birth control, such as creams, gels, films, and sponges. It works by disrupting the membrane of sperm cells, preventing them from fertilizing an egg. However, its use as a spermicide has declined due to concerns about its potential to cause irritation and inflammation in the genital area, which may increase the risk of sexually transmitted infections (STIs) and HIV transmission.

It's important to note that Nonoxynol is not currently recommended for use as a spermicide or microbicide due to its potential health risks. Always consult with a healthcare professional before using any medical product.

A cross-sectional study is a type of observational research design that examines the relationship between variables at one point in time. It provides a snapshot or a "cross-section" of the population at a particular moment, allowing researchers to estimate the prevalence of a disease or condition and identify potential risk factors or associations.

In a cross-sectional study, data is collected from a sample of participants at a single time point, and the variables of interest are measured simultaneously. This design can be used to investigate the association between exposure and outcome, but it cannot establish causality because it does not follow changes over time.

Cross-sectional studies can be conducted using various data collection methods, such as surveys, interviews, or medical examinations. They are often used in epidemiology to estimate the prevalence of a disease or condition in a population and to identify potential risk factors that may contribute to its development. However, because cross-sectional studies only provide a snapshot of the population at one point in time, they cannot account for changes over time or determine whether exposure preceded the outcome.

Therefore, while cross-sectional studies can be useful for generating hypotheses and identifying potential associations between variables, further research using other study designs, such as cohort or case-control studies, is necessary to establish causality and confirm any findings.

Women's health is a branch of healthcare that focuses on the unique health needs, conditions, and concerns of women throughout their lifespan. It covers a broad range of topics including menstruation, fertility, pregnancy, menopause, breast health, sexual health, mental health, and chronic diseases that are more common in women such as osteoporosis and autoimmune disorders. Women's health also addresses issues related to gender-based violence, socioeconomic factors, and environmental impacts on women's health. It is aimed at promoting and maintaining the physical, emotional, and reproductive well-being of women, and preventing and treating diseases and conditions that disproportionately affect them.

"Abortion applicants" is not a standard medical term. However, in general, it may refer to individuals who are seeking to have an abortion procedure performed. This could include people of any gender, although the vast majority of those seeking abortions are women or pregnant individuals. The term "abortion applicant" may be used in legal or administrative contexts to describe someone who is applying for a legal abortion, particularly in places where there are restrictions or requirements that must be met before an abortion can be performed. It is important to note that access to safe and legal abortion is a fundamental human right recognized by many international organizations and medical associations.

I must clarify that I can't provide a "medical definition" of marriage, as the concept of marriage is a social, legal, and often religious institution, rather than a medical one. However, I can tell you that there are no medical definitions associated with the term "marriage." It is typically defined in terms of a committed relationship between two individuals, recognized by law and/or religion, which may involve shared responsibilities, rights, and obligations.

Reproductive health services refer to the provision of health care services that aim to enhance reproductive health and well-being. According to the World Health Organization (WHO), reproductive health is a state of complete physical, mental and social well-being in all matters relating to the reproductive system and its functions and processes.

Reproductive health services may include:

1. Family planning: This includes counseling, education, and provision of contraceptives to prevent unintended pregnancies and promote planned pregnancies.
2. Maternal and newborn health: This includes antenatal care, delivery services, postnatal care, and newborn care to ensure safe pregnancy and childbirth.
3. Sexual health: This includes counseling, testing, and treatment for sexually transmitted infections (STIs), including HIV/AIDS, and education on sexual health and responsible sexual behavior.
4. Infertility services: This includes diagnosis and treatment of infertility, including assisted reproductive technologies such as in vitro fertilization (IVF).
5. Abortion services: This includes safe abortion services, post-abortion care, and counseling to prevent unsafe abortions and reduce maternal mortality and morbidity.
6. Menstrual health: This includes providing access to menstrual hygiene products, education on menstrual health, and treatment of menstrual disorders.
7. Adolescent reproductive health: This includes providing age-appropriate sexual and reproductive health education, counseling, and services to adolescents.

Reproductive health services aim to promote sexual and reproductive health and rights (SRHR), which include the right to access information, education, and services; the right to make informed choices about one's own body and reproduction; and the right to be free from discrimination, coercion, and violence in relation to one's sexuality and reproduction.

A legal abortion is the deliberate termination of a pregnancy through medical or surgical means, carried out in accordance with the laws and regulations of a particular jurisdiction. In countries where abortion is legal, it is typically restricted to certain circumstances, such as:

* To protect the life or health of the pregnant person
* In cases of fetal anomalies that are incompatible with life outside the womb
* When the pregnancy is the result of rape or incest
* When the continuation of the pregnancy would pose a significant risk to the physical or mental health of the pregnant person

The specific circumstances under which abortion is legal, as well as the procedures and regulations that govern it, vary widely from one country to another. In some places, such as the United States, abortion is protected as a fundamental right under certain conditions; while in other countries, such as those with highly restrictive abortion laws, it may only be allowed in very limited circumstances or not at all.

Amenorrhea is a medical condition characterized by the absence or cessation of menstrual periods in women of reproductive age. It can be categorized as primary amenorrhea, when a woman who has not yet had her first period at the expected age (usually around 16 years old), or secondary amenorrhea, when a woman who has previously had regular periods stops getting them for six months or more.

There are various causes of amenorrhea, including hormonal imbalances, pregnancy, breastfeeding, menopause, extreme weight loss or gain, eating disorders, intense exercise, stress, chronic illness, tumors, and certain medications or medical treatments. In some cases, amenorrhea may indicate an underlying medical condition that requires further evaluation and treatment.

Amenorrhea can have significant impacts on a woman's health and quality of life, including infertility, bone loss, and emotional distress. Therefore, it is essential to consult with a healthcare provider if you experience amenorrhea or missed periods to determine the underlying cause and develop an appropriate treatment plan.

Reproductive history is a term used in medicine to describe the past experiences related to reproduction for an individual. This can include information about pregnancies, including the number of pregnancies, outcomes (such as live births, miscarriages, or stillbirths), and any complications that arose during pregnancy or childbirth. It may also include details about contraceptive use, menstrual history, sexually transmitted infections, and any reproductive health issues or surgeries.

This information is often collected by healthcare providers to help assess fertility, plan for future pregnancies, identify potential risks, and provide appropriate care and management of reproductive health conditions. It's also used in research and public health to understand trends and disparities in reproductive outcomes.

LNG-B has been under investigation as a long-lasting injectable contraceptive for women. A single intramuscular injection of an ... "Long-acting contraceptive agents: design of the WHO Chemical Synthesis Programme". Steroids. 41 (3): 243-53. doi:10.1016/0039- ... Goebelsmann U (1986). "Pharmacokinetics of Contraceptive Steroids in Humans". In Gregoire AT, Blye RP (eds.). Contraceptive ... The drug has a well-established safety record owing to the use of levonorgestrel as an oral contraceptive since the 1960s. List ...
van Vloten WA, Sigurdsson V (2004). "Selecting an oral contraceptive agent for the treatment of acne in women". American ... Edelman AB, Cherala G, Stanczyk FZ (October 2010). "Metabolism and pharmacokinetics of contraceptive steroids in obese women: a ... It was the second progestin, after noretynodrel in 1960, to be used in an oral contraceptive. In 1964, additional contraceptive ... Shoupe D (1993). "Injectable Contraceptives and Contraceptive Vaginal Rings". Contraception. Clinical Perspectives in ...
"Effect of low zinc intake and oral contraceptive agents on nitrogen utilization and clinical findings in young women". The ... This effect can be even more pronounced in women taking oral contraceptive medication. Sevelamer, a drug indicated for ... The female of the species releases uric acid into the water during mating, which induces males to release sperm. Although foods ... Both uric acid and ascorbic acid are strong reducing agents (electron donors) and potent antioxidants. In humans, over half the ...
"The police monitored the Clinic from its opening and sent in a female undercover agent to purchase contraceptive supplies. On ... As historian Jill Lepore reports in The Secret History of Wonder Woman, Ethel Byrne was the first female political prisoner in ... confiscated an assortment of contraceptives from pessaries to condoms, along with 20 'books on young women', and arrested ... WOMEN NOISY IN COURT Defendants Bring Before Justices a Mother and Her Six Children as a 'Demonstration'". The New York Times. ...
"The police monitored the Clinic from its opening and sent in a female undercover agent to purchase contraceptive supplies. On ... confiscated an assortment of contraceptives from pessaries to condoms, along with 20 'books on young women', and arrested ... Together, the three women opened the first birth control clinic in the United States in Brooklyn known as the "Brownsville ... All were released the next morning on $500.00 bail." All three women were found guilty, but eventually the verdicts were ...
In men, they are being investigated in the treatment of benign prostatic hyperplasia and also as potential contraceptive agents ... In men, the reduction in LH subsequently leads to rapid suppression of testosterone production in the testes; in women it leads ... Subcutaneously administered agents are also associated with injection-site reactions and abarelix (neither of these being GnRH ... This protocol is likely beneficial in women expected to be hyper-responders, and probably also those expected to be poor ...
A multicenter clinical investigation employing ethinyl estradiol combined with dl-norgestrel as postcoital contraceptive agent ... Evaluation of Female Sterilization Procedures AA Yuzpe, WJ Lancee (1977). Ethinylestradiol and dl-norgestrel as a postcoital ... A multicenter clinical investigation employing ethinyl estradiol combined with dl-norgestrel as postcoital contraceptive agent ... "For his distinguished career in academic reproductive endocrinology and infertility and his dedication to women's health in ...
... or female contraceptives through the use of intravaginal contraceptive devices. Moreover, as serine proteases are important in ... acrosin could thus serve as a novel target for contraceptive agents. Acrosin may represent as a uniquely druggable target due ... This suggests the further role of acrosin inhibitors as potentially viable agents in the prevention of HIV transmission. Adham ... Burck P.J., Zimmerman R.E. An intravaginal contraceptive device for the delivery of an acrosin and hyaluronidase inhibitor" ...
... contraceptive agents, propranolol, and antifungals. Vaginal rings can also be used to deliver medication, including birth ... Human female reproductive system, Mammal female reproductive system, Women and sexuality, Women's health, Anatomy, Gynaecology) ... Female genital mutilation, also known as female circumcision or female genital cutting, is genital modification with no health ... is still under dispute because reports of its location can vary from woman to woman, it appears to be nonexistent in some women ...
... may interfere with various contraceptives, and hence it is advised that women of reproductive age use at least two ... It is a very active anti-angiogenic agent and also acts as an immunomodulator. Pomalidomide was approved in February 2013 by ... In the 1980s, a US task force on women's health concluded that a lack of women's health research (in part due to the FDA ... This led to the National Institute of Health policy that women should, when beneficial, be included in clinical trials. In the ...
Multicenter Clinical Investigation Employing ethinyl estradiol combined with dl-norgestrel as a Postcoital Contraceptive agent ... and 1.3 million women have rape-induced PTSD. A study found that women who were raped were more depressed than women who were ... Female jurors can look at the woman in the witness stand and decide she has done something 'wrong' such as flirting or having a ... Research on women in shelters has shown that women who experience both sexual and physical abuse from intimate partners are ...
However, as many of these therapies have contraceptive effects, they are not ideal for women seeking fertility. Instead, they ... Oral contraceptive pills Androgenic agents (eg danazol) Progestogens (eg medroxyprogesterone acetate) Gonadotropin releasing ... Most women experience this phenomena during normal cycles, rendering many susceptible to endometriosis. Up to 4.1% of women ... A study that included nineteen women received Etanercept before an IVF cycle showed a higher pregnancy rate compared to women ...
Advanced maternal age Female infertility Folliculogenesis Oogenesis Ovarian aging Ovarian follicle Ovarian reserve Premature ... Guidelines suggest possible oral contraceptives in combination with metformin (anti-diabetic medication), and/or anti-androgen ... agents. As PCOS is a highly individualized condition, each individual's management and goals will look different. ... Banerjee S, Banerjee S, Saraswat G, Bandyopadhyay SA, Kabir SN (2014). "Female reproductive aging is master-planned at the ...
Therapies associated with depression include interferons, beta-blockers, isotretinoin, contraceptives, cardiac agents, ... for women, even though suicide attempts are more frequent in women. Depressed people have a higher rate of dying from other ... sustained and sometimes disabling depression experienced by women after giving birth or while a woman is pregnant. DSM-IV-TR ... The most common time of onset is in a person's 20s, with females affected about twice as often as males. The course of the ...
... women with vaginal yeast infection were no more likely to describe their discharge as cottage-cheese like than women without. ... Oral contraceptive use is also associated with increased risk of vaginal thrush. In pregnancy, higher levels of estrogen make a ... Example products are herbal preparations, probiotics and vaginal acidifying agents. Other alternative treatment approaches ... Around 75% of women have at least one vaginal yeast infection at some point in their lives, while nearly half have at least two ...
2016). "Risk of venous thromboembolism in women taking the combined oral contraceptive: A systematic review and meta-analysis ... Oral Contraceptives, and Ovulatory Agents". AMA drug evaluations. Publishing Sciences Group. pp. 540-572. ISBN 978-0-88416-175- ... Women who are not on a birth control pill or hormone therapy have a risk of VTE of about 1 to 5 out of 10,000 women per year. ... It is also used in hormonal birth control for women, in feminizing hormone therapy for transgender women, and in the treatment ...
Oral Contraceptives, and Ovulatory Agents". AMA drug evaluations. Publishing Sciences Group. pp. 540-572. ISBN 978-0-88416-175- ... For female hypogonadism, castration, or primary ovarian failure, 0.1 to 1.0 mg is given weekly in single or divided doses. ... The range of single doses of estrone by intramuscular injection that are typically used clinically in women is 0.1 to 5 mg. ... High doses of intramuscular estrone have been used for prostate cancer in men and for breast cancer in women. Estrone for ...
... antipsychotics Many antiepileptics Theophylline and other methylxanthine drugs Several anesthetic agents Oral contraceptive ... Biliary tract disease Renal dysfunction Pregnant women Obese patients Anticoagulants: Gemfibrozil potentiates the action of ...
Oral Contraceptives, and Ovulatory Agents". AMA drug evaluations. Publishing Sciences Group. pp. 540-572. ISBN 978-0-88416-175- ... It has also been used in feminizing hormone therapy for transgender women and in the treatment of prostate cancer in men. ... As a component of feminizing hormone therapy for transgender women, estradiol dipropionate has been used at dosages of 2 to 10 ... It is also used in feminizing hormone therapy for transgender women. Aside from hormone therapy, estradiol dipropionate is used ...
... of women non-affected by the syndrome. 14% women on oral contraceptives are found to have polycystic ovaries. Ovarian cysts are ... Although these agents have shown significant efficacy in clinical trials (for oral contraceptives, in 60-100% of individuals), ... Although 80% of PCOS presents in women with obesity, 20% of women diagnosed with the disease are non-obese or "lean" women. ... in women with PCOS and 1.57 nmol/L (45 ng/dL) in women without PCOS. In a 1995 study of 1,741 women with PCOS, mean ...
Potential causative agents include oral contraceptive pills, spironolactone, and anabolic steroids. High levels of prolactin in ... As in females, estrogen stimulates the growth of breast tissue in males. In addition to directly stimulating breast tissue ... 60-90% of male and female newborns may show breast development at birth or in the first weeks of life. During pregnancy, the ... Physiologic or normal gynecomastia can occur at three timepoints in life: shortly after birth in both female and male infants, ...
Chinnatamby, S. (November 01, 1971). A Comparison of the Long-Acting Contraceptive Agents Norethisterone Oenanthate and ... At the end of her life, she bequeathed her home in Colombo to the University of Colombo, for use as residence for women ... Chinnatamby, Siva (1971). "A Comparison of the Long-Acting Contraceptive Agents Norethisterone Oenanthate and ... Siva Chinnatamby (c.1921/3 - 2000) was a Sri Lankan obstetrician who pioneered the use of modern contraceptives in the country ...
... of megestrol acetate in women receiving IM injection of estradiol-megestrol long-acting injectable contraceptive". The Chinese ... In the group of new parenteral progestational agents, three substances developed by Karl Junkmann1,2 are the most outstanding ... Goebelsmann U (1986). "Pharmacokinetics of Contraceptive Steroids in Humans". In Gregoire AT, Blye RP (eds.). Contraceptive ... In terms of producing full progestogenic changes on the endometrium in women, 75 to 100 mg/day oral OHPA is equivalent to 20 mg ...
... as well as other less well-known agents. These agents are generally used if oral contraceptives and NSAIDs are ineffective. ... Endometriomas can increase the risk of ovarian cancer in reproductive women, decrease normal ovarian function, and cause pain ... Therapy with these agents has a large number of sometimes permanent side effects, such as hot flushes, loss of bone mass, ... This can also be accomplished with progestational agents (i.e., medroxyprogesterone acetate), danazol, gestrinone, or ...
Oral Contraceptives, and Ovulatory Agents". AMA drug evaluations. Publishing Sciences Group. pp. 540-572. ISBN 978-0-88416-175- ... In transgender women, estradiol valerate given by intramuscular injection is usually used at a dosage of 5 to 20 mg, but up to ... Estradiol valerate has been used at very high doses of 40 to 100 mg once per week in women and men, without overt signs of ... Low-dose oral estradiol valerate (2-6 mg/day) has been used in the treatment of breast cancer in women who were previously ...
... to use women's and girls' restrooms, locker rooms, showers, sleeping areas and other areas that are designated for females only ... He later became a real estate agent and investor. The Duggars' income is derived from rental proceeds of commercial properties ... They resumed using oral contraceptives after his birth, but conceived again, despite this precaution; however, Michelle ... Shorts and tank tops are prohibited, and the women do not wear skirts that go above the knee. According to Michelle Duggar, ...
Combined injectable contraceptives (CICs) are a form of hormonal birth control for women. They consist of monthly injections of ... Progestational Drugs and Antifertility Agents. Vol. II. Pergamon Press. pp. 13-24. ISBN 978-0080168128. OCLC 278011135. Henzl ... Garza-Flores J, Hall PE, Perez-Palacios G (1991). "Long-acting hormonal contraceptives for women". J. Steroid Biochem. Mol. ... Rivera R, Yacobson I, Grimes D (1999). "The mechanism of action of hormonal contraceptives and intrauterine contraceptive ...
... of the general female population and 2 to 11% of asymptomatic women are affected. In addition, 11% of women in a general ... These agents, although efficacious, were associated with intolerable side effects. The current armamentarium of hormonal agents ... Limited evidence indicates that the use of combined oral contraceptives is associated with a reduced risk of endometriosis, as ... of women with cystic ovarian lesions, and 5% of women with deep endometriosis do not have pain. A major symptom of ...
They would arrive in San Francisco on August 8. Women were allowed to be part of jury trial in the United Kingdom for the first ... Born: Martin Knowlton, American travel agent and hostel administrator, who established Elderhostel; in Dallas (d. 2009) France ... prohibited the sale or prescription of contraceptives, as well as forbidding the distribution of "antinatalist propaganda", as ... Japan's House of Representatives rejected a resolution to grant women the right to vote, with only 155 in favor and 283 against ...
The endometrium of women with HMB have higher levels of prostaglandin (E2, F2alpha and others) when compared with women with ... Usually, oral combined contraceptive or progesterone only pills may be taken for a few months, but for longer-term treatment ... First line Intrauterine device with progesterone Second Line Tranexamic acid an antifibrinolytic agent Nonsteroidal anti- ... The first line treatment option for women with HMB and no identified pathology, fibroids less than 3 cm in diameter, and/or ...

No FAQ available that match "contraceptive agents female"

No images available that match "contraceptive agents female"